MOBILE VIEW  | 

CHLORINE GAS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Chlorine combines with tissue water to produce hydrochloric acid, producing injury and reactive oxygen species.

Specific Substances

    1) Bertholite
    2) Chloor (Dutch)
    3) Chlor (German)
    4) Chlore (French)
    5) Chloro (Italian)
    6) Molecular chlorine
    7) Molecular Formula: Cl2
    8) CAS 7782-50-5
    9) CHLORINE DIOXIDE HYDRATE, FROZEN
    1.2.1) MOLECULAR FORMULA
    1) Cl2

Available Forms Sources

    A) FORMS
    1) Chlorine is available in a semiconductor, high purity grade at 99.5% purity (liquid phase); a liquefied gas grade; a research grade with a minimum purity of 99.99%; a water works grade, and technical gas and liquid grades (HSDB , 2001; Lewis, 1997).
    B) SOURCES
    1) Chlorine is not found free in nature due to its reactivity with other chemicals. Instead, it is found as sodium chloride in land locked lakes, as rock salt in underground deposits, in brines, and in natural deposits of sylvite and carnallite (Bingham et al, 2001).
    2) Swimming pool chlorinator tablets or pellets may result in chlorine gas exposure (Wood et al, 1987).
    3) For mixtures producing chlorine gas, see the SODIUM HYPOCHLORITE management.
    C) USES
    1) Chlorine is used to manufacture other chemicals. These include solvents such as carbon tetrachloride, trichloroethylene, 1,1,1-trichloroethane, tetrachloroethylene, and methylene chloride, pesticides and herbicides, plastics, vinyl chloride, and vinylidene chloride. It is also used in making refrigerants and propellants such as halocarbons and methyl chloride (CGA, 1999; HSDB , 2001).
    a) Many other chemicals are produced from chlorine including other chlorinated hydrocarbons, polychloroprene (neoprene), polyvinyl chloride, hydrogen chloride, ethylene dichloride, hypochlorous acid, metallic chlorides, chlorinated benzenes, phosgene, chloroform, chlorinated paraffins, chloracetic acid, and chlorinated lime. It is an important reagent in synthetic chemistry (Bingham et al, 2001; Budavari, 2000; HSDB , 2001; Lewis, 1997).
    b) Chlorine is used to make sodium hypochlorite, an ingredient in bleach, deodorizers and disinfectants. Chlorine is used to bleach pulp, paper, and fabrics (CGA, 1999; OHM/TADS , 2001).
    1) Chlorine is used extensively in pulpmills, where wood chips are processed into pulp as part of the paper manufacturing process (Kennedy et al, 1991).
    2) Chlorine is employed in purifying drinking and swimming water, for sanitation of industrial and sewage wastes and other disinfecting uses, and as a ring chlorination/oxidation reagent (Ashford, 1994; Bingham et al, 2001; CGA, 1999; HSDB , 2001; OHM/TADS , 2001).
    3) Chlorine is used for detinning and dezincing iron, metal fluxing, and for degassing of aluminum melts (Budavari, 2000; CGA, 1999; Hathaway et al, 1996).
    4) A limited use for chlorine is in processing meats, fish, and fresh produce. Miscellaneous uses include the production of pharmaceuticals, cosmetics, lubricants, flame proofers, adhesives, food additives, and hydraulic fluids, in special batteries with zinc and lithium, and its use in shrink-proofing wool (ACGIH, 1991; Bingham et al, 2001; Lewis, 1997).
    5) It has been used as a poisonous gas for military purposes under the name bertholite (Budavari, 2000).
    6) The extinct nuclide Cl-36 is used to determine the geological age of meteors (Budavari, 2000).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: Chlorine is a greenish-yellow, noncombustible gas at room temperature and atmospheric pressure. It is used in industrial bleaching operations, sewage treatment, swimming pool chlorination tablets, and chemical warfare. It can be generated when bleach is mixed with other cleaning products.
    B) TOXICOLOGY: The primary effects are due to local tissue injury rather than to systemic absorption. Cellular injury is believed to result from the oxidation of functional groups in cell components, from reactions with tissue water to form hypochlorous acid and hydrochloric acid, and from the generation of free oxygen radicals. Although the idea that chlorine causes direct tissue damage by generating free oxygen radicals was once accepted, this idea is now controversial.
    C) EPIDEMIOLOGY: Chlorine gas is one of the most common single-irritant inhalation exposures, occupationally and environmentally. In a recent study of 323 cases of inhalation exposures reported to poison control centers, the largest single exposure (21%) was caused by mixing bleach with other products.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE POISONING: Cough, shortness of breath, chest pain, burning sensation in the throat and substernal area, nausea or vomiting, ocular and nasal irritation, choking, muscle weakness, dizziness, abdominal discomfort, and headache.
    2) SEVERE POISONING: Upper airway edema, laryngospasm, severe pulmonary edema, pneumonia, persistent hypoxemia, respiratory failure, acute lung injury, and metabolic acidosis.
    3) PREDISPOSING FACTORS: Patients with asthma, reactive airways, or COPD may develop respiratory irritation at lower concentrations.
    0.2.3) VITAL SIGNS
    A) WITH POISONING/EXPOSURE
    1) Tachycardia and tachypnea are common. Severe exposure may cause cardiovascular collapse and respiratory arrest.
    0.2.4) HEENT
    A) WITH POISONING/EXPOSURE
    1) Green hair, dental enamel erosion, conjunctivitis, lacrimation, and nasal and throat irritation may occur. Anosmia has been reported.
    0.2.5) CARDIOVASCULAR
    A) WITH POISONING/EXPOSURE
    1) Tachycardia and initial hypertension followed by hypotension may occur. Cardiovascular collapse may ensue following severe exposure.
    0.2.6) RESPIRATORY
    A) WITH POISONING/EXPOSURE
    1) A feeling of burning and suffocation, coughing, choking, laryngeal edema, bronchospasm, and hypoxia may occur. In high concentrations, syncope and almost immediate death may occur. Acute lung injury is common after severe exposure.
    2) Multiple exposures produced flulike symptoms and high risk of developing reactive airway dysfunction syndrome.
    3) Persistent pulmonary dysfunction has been reported in some individuals following severe inhalational exposure.
    0.2.7) NEUROLOGIC
    A) WITH POISONING/EXPOSURE
    1) Headache may develop. Agitation and anxiety may develop in patients with significant respiratory compromise.
    0.2.8) GASTROINTESTINAL
    A) WITH POISONING/EXPOSURE
    1) Vomiting may occur following initial exposure.
    0.2.11) ACID-BASE
    A) WITH POISONING/EXPOSURE
    1) Following severe exposure, metabolic acidosis secondary to hypoxemia may be noted.
    0.2.14) DERMATOLOGIC
    A) WITH POISONING/EXPOSURE
    1) Dermal exposure may cause erythema, pain, irritation, and cutaneous burns.
    0.2.20) REPRODUCTIVE
    A) Chlorine (as hypochlorite) is teratogenic in experimental animals. Evaluations of sperm morphology in murine experiments demonstrated the presence of mutations.
    0.2.21) CARCINOGENICITY
    A) Lymphoma has been observed in relation to water treatment with chlorine. Associations with increased renal, bladder, and gastric cancers have also been found, but firm conclusions cannot be drawn because of mixed exposures with caustic acids.

Laboratory Monitoring

    A) Obtain a chest radiograph and monitor pulse oximetry in patients with respiratory distress.
    B) Obtain arterial blood gases in patients with severe respiratory distress.

Treatment Overview

    0.4.3) INHALATION EXPOSURE
    A) MANAGEMENT OF MILD TOXICITY
    1) Provide supplemental oxygen to maintain PaO2 of 60 mmHg or greater. Bronchodilators (inhaled albuterol or other beta-agonists, and anticholinergics) have been used frequently for the management of respiratory symptoms. Lidocaine (1% solution) added to nebulized albuterol results in both analgesic and cough suppressant actions. Nebulized sodium bicarbonate (3.75%) has been used in case series and is suggested by some experts. Perform an ophthalmologic exam (including visual acuity and slit lamp) in any patient with persistent eye irritation.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Aggressive use of inhaled beta-agonists, lidocaine, and nebulized sodium bicarbonate for bronchospasm. Corticosteroids may also be useful for severe bronchospasm. Early intubation for laryngospasm or severe respiratory distress. Treat respiratory failure with positive-pressure ventilation. Positive end-expiratory pressure (PEEP) (8 to 10 mmHg) and inverse ratio ventilation may be beneficial in acute lung injury.
    C) DECONTAMINATION
    1) PREHOSPITAL: Remove the individual from the toxic environment. Administer humidified oxygen if respiratory irritation develops. Remove contaminated clothing.
    2) HOSPITAL: Irrigate exposed eyes with copious amounts of normal saline. Remove contaminated clothing and wash exposed skin with water.
    D) AIRWAY MANAGEMENT
    1) Perform endotracheal intubation if indicated (eg, persistent hypoxemia, severe bronchospasm, stridor, severe respiratory distress, or laryngeal edema).
    E) ANTIDOTE
    1) There is no specific antidote.
    F) ENHANCED ELIMINATION
    1) There is no role for this procedure.
    G) PATIENT DISPOSITION
    1) HOME CRITERIA: Patients who are asymptomatic and those who have mild, transient irritation (eye, skin, or respiratory) may be observed at home.
    2) OBSERVATION CRITERIA: Patients with more than transient eye or pulmonary irritation should be sent to a healthcare facility for treatment and observation.
    3) ADMISSION CRITERIA: Patients with persistent respiratory symptoms after 4 to 6 hours should be admitted. Patients with severe respiratory distress or upper airway injury should be admitted to an intensive care unit.
    4) CONSULT CRITERIA: Consult critical care personnel if patient exhibits severe and protracted respiratory distress. Consult an ophthalmologist for patients with ocular burns. Consult a medical toxicologist or poison center for patients with persistent symptoms.
    H) PITFALLS
    1) Distinguishing toxic air levels from permissible air levels may be difficult until irritative symptoms are present. History of chlorine exposure may be difficult to obtain in some settings (eg, swimming pools, mixing of cleaning products).
    I) TOXICOKINETICS
    1) Chlorine is a greenish-yellow, noncombustible gas at room temperature and atmospheric pressure. The intermediate water solubility of chlorine accounts for its effect on the upper airway and the lower respiratory tract. In addition, the density of the gas is greater than that of air, causing it to remain near ground level and increasing exposure time. The odor threshold for chlorine is approximately 0.3 to 0.5 parts per million (ppm).
    J) DIFFERENTIAL DIAGNOSIS
    1) This should include diseases or exposures that produce acute respiratory distress (eg, inhalation of acid or alkaline mists, asthma, COPD).
    0.4.4) EYE EXPOSURE
    A) MANAGEMENT OF MILD TOXICITY
    1) Perform an ophthalmologic exam (including visual acuity and slit lamp) in any patient with persistent eye irritation.
    B) DECONTAMINATION
    1) PREHOSPITAL: Irrigate exposed eyes with normal saline.
    2) HOSPITAL: Irrigate exposed eyes with copious amounts of normal saline. In cases of suspected ocular injury, determine initial pH using a reagent strip. Continue irrigation with 0.9% saline until the pH returns to 7 to 8.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) DECONTAMINATION
    a) PREHOSPITAL: Remove contaminated clothing and wash exposed skin with water.
    b) HOSPITAL: Remove contaminated clothing and wash exposed skin with water.

Range Of Toxicity

    A) The range of toxicity depends on the concentration of chlorine gas, duration of exposure, water content of the tissues exposed, physical location of exposure (eg, enclosed space), and individual susceptibility. It has been estimated that at 1 to 3 parts per million (ppm) mild mucous membrane irritation can occur; 5 to 15 ppm will cause moderate irritation of the upper respiratory tract; and 30 ppm will produce immediate chest pain, vomiting, dyspnea, and cough. Exposure to concentrations of 35 to 51 ppm are lethal in 60 to 90 minutes, and 1000 ppm is lethal within a few minutes.
    B) The OSHA time-weighted average permissible exposure limit (TWA PEL) is 1 ppm, and the NIOSH immediately dangerous to life and health (IDLH) level is 10 ppm.
    C) One or two breaths of gas accumulating above swimming pool or spa chlorinator tablets may cause marked respiratory distress and hypoxemia.

Summary Of Exposure

    A) USES: Chlorine is a greenish-yellow, noncombustible gas at room temperature and atmospheric pressure. It is used in industrial bleaching operations, sewage treatment, swimming pool chlorination tablets, and chemical warfare. It can be generated when bleach is mixed with other cleaning products.
    B) TOXICOLOGY: The primary effects are due to local tissue injury rather than to systemic absorption. Cellular injury is believed to result from the oxidation of functional groups in cell components, from reactions with tissue water to form hypochlorous acid and hydrochloric acid, and from the generation of free oxygen radicals. Although the idea that chlorine causes direct tissue damage by generating free oxygen radicals was once accepted, this idea is now controversial.
    C) EPIDEMIOLOGY: Chlorine gas is one of the most common single-irritant inhalation exposures, occupationally and environmentally. In a recent study of 323 cases of inhalation exposures reported to poison control centers, the largest single exposure (21%) was caused by mixing bleach with other products.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE POISONING: Cough, shortness of breath, chest pain, burning sensation in the throat and substernal area, nausea or vomiting, ocular and nasal irritation, choking, muscle weakness, dizziness, abdominal discomfort, and headache.
    2) SEVERE POISONING: Upper airway edema, laryngospasm, severe pulmonary edema, pneumonia, persistent hypoxemia, respiratory failure, acute lung injury, and metabolic acidosis.
    3) PREDISPOSING FACTORS: Patients with asthma, reactive airways, or COPD may develop respiratory irritation at lower concentrations.

Vital Signs

    3.3.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Tachycardia and tachypnea are common. Severe exposure may cause cardiovascular collapse and respiratory arrest.
    3.3.2) RESPIRATIONS
    A) WITH POISONING/EXPOSURE
    1) RESPIRATORY ARREST: Severe exposure may cause laryngospasm and respiratory arrest (Anon, 1984).
    3.3.4) BLOOD PRESSURE
    A) WITH POISONING/EXPOSURE
    1) CARDIOVASCULAR COLLAPSE: Severe exposure may cause cardiovascular collapse (Done, 1976; Noe, 1963).
    3.3.5) PULSE
    A) WITH POISONING/EXPOSURE
    1) TACHYCARDIA: Severe exposure may cause tachycardia (Mohan et al, 2010; Kose et al, 2009; Van Sickle et al, 2009; Vohra & Clark, 2006; Done, 1976; Noe, 1963).

Heent

    3.4.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Green hair, dental enamel erosion, conjunctivitis, lacrimation, and nasal and throat irritation may occur. Anosmia has been reported.
    3.4.2) HEAD
    A) WITH POISONING/EXPOSURE
    1) GREEN HAIR, SWIMMING POOLS: Green hair coloration has been described in blonde or grey-headed individuals following regular swimming in chlorinated water, due to an interaction between copper algicides, chlorine, and acid in improperly chlorinated pools (Lampe et al, 1977).
    a) SHAMPOOS: Green hair caused by shampooing has occurred. The cause was copper leaching from household plumbing following water acidification due to non-pH-controlled fluoridation (Barrett, 1977; Cooper & Goodman, 1975).
    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) Conjunctivitis and eye irritation have been reported (CDC, 1991; Anon, 1984; Noe, 1963). Exposure to concentrations as low as 3 ppm to 6 ppm in air can cause a burning and stinging sensation, blepharospasm, redness, and lacrimation (Grant & Schuman, 1993).
    a) INCIDENCE: In a series of 86 patients whose chlorine exposure cases were reported to a poison control center, 3 (4%) developed eye irritation or burning (Bosse, 1994). In a retrospective review of 598 poison center chlorine cases, 248 cases (41.5%) involved exposure to tablets; 320 (53.5%), exposure to liquid chlorine; and the remainder, to both. Eye irritation was reported in 8.5% of patients (LoVecchio et al, 2005).
    1) In a series of 281 workers who had been repeatedly exposed to chlorine, 77% complained of eye irritation (Courteau et al, 1994).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Nasal irritation has been reported (Courteau et al, 1994; CDC, 1991; Noe, 1963).
    a) INCIDENCE: In a series of 86 patients whose chlorine exposure cases were reported to a poison control center, 5 (6%) developed nasal irritation or burning (Bosse, 1994). In a retrospective review of 598 poison center chlorine cases, 248 cases (41.5%) involved exposure to tablets; 320 (53.5%), exposure to liquid chlorine; and the remainder, to both. Nasal complaints were reported in 9.7% of patients (LoVecchio et al, 2005).
    2) ANOSMIA: A case of anosmia following chlorine exposure has been reported (Benjamin & Pickles, 1997).
    3) INTERACTION, ALLERGIC RHINITIS: Individuals with seasonal allergic rhinitis who were exposed to chlorine at 0.5 ppm for 15 minutes had a much greater nasal airway resistance increase than nonallergic controls (Shusterman et al, 1998).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) HOARSENESS: Throat irritation has been reported (Courteau et al, 1994; Noe, 1963).
    a) INCIDENCE: In a series of 86 patients whose chlorine exposure cases were reported to a poison control center, 12 (14%) developed throat irritation, burning, or soreness (Bosse, 1994).
    1) In a series of 281 workers who had been repeatedly exposed to chlorine, 78% complained of throat irritation (Courteau et al, 1994).
    2) DENTAL ENAMEL EROSION: Competitive swimmers exposed to gas-chlorinated swimming pools developed dental enamel erosion. A pool water sample had a pH of 2.7 (Centerwall et al, 1986).

Cardiovascular

    3.5.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Tachycardia and initial hypertension followed by hypotension may occur. Cardiovascular collapse may ensue following severe exposure.
    3.5.2) CLINICAL EFFECTS
    A) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Weak pulse, hypertension followed by hypotension, and cardiovascular collapse may occur (Done, 1976; Noe, 1963).
    B) TACHYCARDIA
    1) WITH POISONING/EXPOSURE
    a) Severe exposure may cause tachycardia (Mohan et al, 2010; Kose et al, 2009; Vohra & Clark, 2006; Done, 1976; Noe, 1963).
    b) CASE SERIES: Following a train derailment that released 42 to 60 tons of chlorine gas within a small town, tachycardia (greater than 100 bpm) was reported as an immediate and persistent finding in 27 of 63 patients (43%) and as a delayed finding in 8 of 63 patients (13%) (Van Sickle et al, 2009).
    C) VENTRICULAR ARRHYTHMIA
    1) WITH POISONING/EXPOSURE
    a) Two cases have been reported in which exposure to chlorine gas produced ventricular ectopic beats. Neither required the use of antiarrhythmics (Edwards et al, 1983).
    D) HYPERTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: Following a train derailment that released 42 to 60 tons of chlorine gas within a small town, hypertension (systolic pressure greater than 140 mmHg or diastolic pressure greater than 90 mmHg) was reported as an immediate and persistent finding in 18 of 63 patients (29%) and as a delayed finding in 10 of 63 patients (16%) (Van Sickle et al, 2009).
    E) CARDIOMEGALY
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: Derailment of a train carrying three 90-ton tanker cars of chlorine released 42 to 60 tons of chlorine gas within a small town, resulting in the hospitalization of 71 people and the deaths of 9 people (8 at the scene of the accident and 1 on the first day of hospitalization). Although asphyxia was determined to be the primary cause of death, autopsies detected cardiomegaly in 8 of the 9 deceased individuals. Cardiomegaly was also a radiologic finding in 3 of the hospitalized patients (Van Sickle et al, 2009).
    F) MYOCARDIAL INFARCTION
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 74-year-old woman, with diabetes, presented to the emergency department profoundly hypoxic and (oxygen saturation 50%) and comatose after inhaling fumes from the combination of sodium hypochloride and hypochloric acid. Examination of the patient revealed tachycardia, miosis, rales and rhonchi of the lungs, and a Glasgow Coma Scale score of 5. Laboratory data revealed respiratory acidosis and an elevated blood glucose level (946 mg/dL). An ECG demonstrated anterior superior hemiblock and loss of R-wave progression, and an elevation in her cardiac enzymes was noted, indicating a non-Q myocardial infarction. A brain CT scan initially detected no abnormalities except for slight edema; however, a repeat CT, performed 1 day later, revealed an infarct of the right middle cerebral artery and effacement of right sulci. Despite aggressive supportive care, the patient's condition continued to deteriorate and she died on hospital day 5 (Kose et al, 2009).

Respiratory

    3.6.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) A feeling of burning and suffocation, coughing, choking, laryngeal edema, bronchospasm, and hypoxia may occur. In high concentrations, syncope and almost immediate death may occur. Acute lung injury is common after severe exposure.
    2) Multiple exposures produced flulike symptoms and high risk of developing reactive airway dysfunction syndrome.
    3) Persistent pulmonary dysfunction has been reported in some individuals following severe inhalational exposure.
    3.6.2) CLINICAL EFFECTS
    A) COUGH
    1) WITH POISONING/EXPOSURE
    a) INCIDENCE: In a series of 86 patients whose chlorine exposure cases were reported to a poison control center, 45 (52%) developed cough (Bosse, 1994). In a retrospective review of 598 poison center chlorine cases, 248 cases (41.5%) involved exposure to tablets; 320 (53.5%), exposure to liquid chlorine; and the remainder, to both. Cough was reported in 70.1% of patients (LoVecchio et al, 2005).
    b) INCIDENCE: In a series of 281 workers who had been repeatedly exposed to chlorine, 67% complained of cough (Courteau et al, 1994).
    B) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) INCIDENCE: In a series of 86 patients whose chlorine exposure cases were reported to a poison control center, 44 (51%) developed shortness of breath (Bosse, 1994). In a retrospective review of 598 poison center chlorine cases, 248 cases (41.5%) involved exposure to tablets; 320 (53.5%), exposure to liquid chlorine; and the remainder, to both. Shortness of breath was reported in 38.1% of patients (LoVecchio et al, 2005).
    b) INCIDENCE: In a series of 281 workers who had been repeatedly exposed to chlorine, 54% complained of shortness of breath (Courteau et al, 1994).
    c) CASE REPORT: A 7-year-old developed dyspnea and coughing after inhaling chlorine fumes from a can of chlorine tablets used for an indoor swimming pool. The patient was treated with 100% oxygen (O2) via face mask to maintain an O2 saturation above 94% and was also given 1 treatment of albuterol by nebulizer without improvement. The patient was then given nebulized sodium bicarbonate over 20 minutes, with a dramatic improvement in symptoms and a decrease in nasal flaring and retraction. The patient was discharged the following day with no further symptoms (Douidar, 1997).
    d) CASE REPORT: Coughing and dyspnea occurred in a 9-year-old girl who was swimming and inhaled chlorine released from aerosolized swimming pool purification tablets. Her O2 saturation the day following exposure was 90% on room air. Lung examination revealed moderate intercostal and supraventricular retractions, tachypnea, and bilateral wheezing. A chest radiograph showed bilateral interstitial infiltrates. The patient recovered with supplemental O2 and bronchodilator therapy. After 4 months, pulmonary function tests indicated a mild reversible obstructive pattern, but medication was not required to perform normal activities of daily living (Vohra & Clark, 2006).
    e) CASE SERIES: In a series of 13 children who had been exposed to chlorine gas at a swimming pool, 5 patients were admitted to the hospital secondary to hypoxia, with pulse oximetry reading ranging from 85% to 93% on room air. Of these 5 patients, 4 were found to have mild carbon dioxide (CO2) retention with PCO2 readings of 45, 47, 47, and 50 mmHg. The authors suggested that CO2 retention may occur relatively frequently following chlorine gas exposure (Sexton & Pronchik, 1998).
    f) CASE REPORT: A 42-year-old man developed respiratory distress following inhalation of chlorine powder used to treat his pool. Dyspnea, cough, chest tightness, and eye pain, tearing, and blurred vision occurred shortly after inhalation. Physical examination revealed mild expiratory wheezes and bilaterally injected sclerae, Although his initial chest X-ray was unremarkable and he received treatment with bronchodilators, his condition rapidly worsened and he developed increasing dyspnea, cough, and bilateral crackles. He was intubated approximately 60 hours after exposure for worsening symptoms and a post intubation chest x-ray revealed pulmonary edema, acute respiratory distress syndrome, and small pleural effusions. A bronchoscopy demonstrated hyperemic mucosa and mucosal pallor. With supportive care, including ventilator support and inhaled beta-agonists, the patient was eventually extubated and discharged without sequelae 14 days later. A follow-up one year later revealed no long term lung related complications (Endrizzi et al, 2015).
    C) BRONCHOSPASM
    1) WITH POISONING/EXPOSURE
    a) Typical findings following mild to moderate acute exposure include wheezing, throat irritation, coughing, dyspnea, burning chest pain, and feelings of suffocation (Centers for Disease Control and Prevention (CDC), 2011; Mohan et al, 2010; Courteau et al, 1994; Anon, 1984). Bronchospasm may occur with acute exposure (Sexton & Pronchik, 1998).
    b) INCIDENCE: In a series of 86 patients whose chlorine exposure cases were reported to a poison control center, 29 (34%) developed chest pain, burning, irritation, or heaviness (Bosse, 1994).
    D) INJURY OF UPPER RESPIRATORY TRACT
    1) WITH POISONING/EXPOSURE
    a) Laryngeal edema, hoarseness, and stridor may develop (Hathaway et al, 1996; Martinez & Long, 1995; Anon, 1984).
    E) APNEA
    1) WITH POISONING/EXPOSURE
    a) More severe exposures may lead to laryngeal spasms, cyanosis, and respiratory arrest (Lawson, 1981; Hedges & Morrissey, 1979; Done, 1976; Noe, 1963).
    F) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) More severe exposures may lead to acute lung injury (Van Sickle et al, 2009; Sexton & Pronchik, 1998; Heidemann & Goetting, 1991), and death may follow within 24 hours (Martinez & Long, 1995; Anon, 1984).
    b) CASE REPORT: A 14-year-old healthy male with a history of asthma developed respiratory failure and acute lung injury following exposure to chlorine gas (result of mixing vinegar and household bleach in an unventilated room). The patient was managed using mechanical ventilation with positive end-expiratory pressure (up to 12 mmHg), along with intravenous methylprednisolone and nebulized albuterol. The patient was successfully extubated on day 19, with no evidence of permanent pulmonary injury (Traub et al, 2002).
    c) CASE REPORT: A 42-year-old man developed respiratory distress following inhalation of chlorine powder used to treat his pool. Dyspnea, cough, chest tightness, and eye pain, tearing, and blurred vision occurred shortly after inhalation. Physical examination at hospital arrival revealed mild expiratory wheezes and bilaterally injected sclerae. Although his initial chest X-ray was unremarkable and he received treatment with bronchodilators, his condition rapidly worsened and he developed increasing dyspnea, cough, and bilateral crackles. He was intubated and a second chest x-ray revealed pulmonary edema, acute respiratory distress syndrome, and small pleural effusions. A bronchoscopy demonstrated hyperemic mucosa and mucosal pallor. With supportive care, including ventilator support and inhaled beta-agonists, the patient was eventually extubated and discharged without sequelae 14 days later (Endrizzi et al, 2015).
    G) PNEUMONITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Dyspnea, hypoxemia, and pneumonitis occurred in a 9-year-old girl who, while swimming, was exposed to chlorine released from aerosolized swimming pool purification tablets. Her oxygen saturation approximately 12 hours after exposure was 90% on room air. Lung examination revealed moderate intercostal and supraventricular retractions, tachypnea, and bilateral wheezing. A chest radiograph showed bilateral interstitial infiltrates. The patient recovered with supplemental oxygen and bronchodilator therapy. After 4 months, pulmonary function tests revealed a mild, reversible obstructive pattern, but medication was not required to perform normal activities of daily living (Vohra & Clark, 2006).
    H) ACUTE BRONCHIOLITIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 23-year-old healthy man developed acute bronchiolitis after exposure to chlorine gas (concentration unknown) for approximately 5 minutes while exercising. Respiratory symptoms became progressively worse (tachypnea, bilateral wheezing), and a chest x-ray obtained 36 hours after exposure showed diffuse small nodular opacities. Scant blood-tinged sputum was also observed. A CT scan of the chest was consistent with diffuse bronchiolitis (ie, ill-defined centrilobular nodules along the peribronchovascular structure and mild air trapping). Following treatment (albuterol and prednisone), the patient was discharged; pulmonary functions studies repeated at 12 weeks were markedly improved (Kanne et al, 2006; Parimon et al, 2004).
    I) BRONCHITIS
    1) WITH POISONING/EXPOSURE
    a) Flexible fiberoptic bronchoscopy 3 to 7 days after exposure to chlorine gas revealed evidence of tracheobronchitis (congestion, edema, scattered hemorrhage, and sloughing) in 14 patients. Of the 9 patients with previously normal lungs, 6 had evidence of mild obstructive lung disease, and 2 had mild restrictive disease on initial pulmonary function testing. Pulmonary function tests returned to normal over the next 6 months. In the 5 patients with preexisting COPD, there was no improvement in pulmonary function tests 6 months after exposure (Abhyankar et al, 1989).
    J) REACTIVE AIRWAYS DYSFUNCTION SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Persistent reactive airways dysfunction syndrome (RADS) has occasionally been reported after exposure to chlorine gas (Mohan et al, 2010).
    b) CASE REPORT: A 30-year-old man with a history of childhood asthma not requiring medication for 20 years developed severe shortness of breath and wheezing after a chlorine gas cylinder exploded in his face. Nocturnal and exertional dyspnea and wheezing and reversible airflow obstruction requiring inhaled bronchodilators and steroids persisted for 6 years (Donnelly & FitzGerald, 1990).
    c) CASE REPORT: A 25-year-old man with a history of mild childhood asthma not requiring treatment for 20 years developed dyspnea and wheezing after working in a chlorine-filled enclosed environment. He was treated with aminophylline, inhaled beta-agonists, and inhaled and oral steroids over the next 4 years. Pulmonary function testing 4 years after exposure revealed severe partially reversible obstructive disease (Moore & Sherman, 1991).
    d) CASE REPORT: A 39-year-old woman with atopy and a family history of asthma developed mild reversible obstructive disease, as shown by pulmonary function testing, after mixing sodium hypochlorite and hydrochloric acid in a confined space. Symptoms persisted for 2 years after exposure (Deschamps et al, 1994).
    e) CASE REPORT: Two patients developed reactive airways disease after chlorine exposure. Both patients improved over time (Demeter & Cordasco, 1992).
    f) CASE SERIES: In a series of 71 workers considered at moderate to high risk of developing RADS because of repeated exposure to chlorine, 51 underwent spirometry 18 to 24 months after exposure ended. Of those workers, 16 had obstructive pulmonary disease and 29 showed hyperresponsiveness on methacholine challenge (Bherer et al, 1994).
    1) Twenty of the subjects with hyperresponsiveness were retested 30 to 36 months after exposure. There were no significant overall changes in FEV1, but 6 of the 18 subjects who underwent methacholine challenge on both occasions showed diminished or no hyperresponsiveness during the second test, 30 to 36 months after exposure (Malo et al, 1994).
    K) MEDIASTINAL EMPHYSEMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 26-year-old woman presented with severe dyspnea and wheezing approximately 2 days after inhaling the chlorine gas produced by mixing 5% sodium hypochlorite and 18% hydrochloric acid. Physical examination revealed hyperemia and edema of her vocal cords and laryngeal structures, and diffuse rhonchus was heard following auscultation of her lungs. A CT scan of the patient's neck and thorax indicated emphysema of the neck and pneumomediastinum. Following treatment with 50% humidified oxygen and administration of bronchodilators and IV corticosteroid infusion, the patient recovered. A repeat CT scan performed 6 days later showed complete resolution of the pneumomediastinum (Akdur et al, 2006).
    b) CASE REPORTS: Two patients, a 13-year-old girl and a 15-year-old boy, presented to the emergency department 10 minutes after inhaling chlorine gas. Chest radiographs of both patients revealed pulmonary edema and a chest CT scan indicated pneumomediastinum. Both patients recovered following supportive care, including oxygen therapy (Li et al, 2011).
    L) DISORDER OF RESPIRATORY SYSTEM
    1) WITH POISONING/EXPOSURE
    a) PULMONARY SEQUELAE: Increased airway reactivity to inhaled methacholine and decreased residual volume have been described for up to 12 years following an acute exposure (Schwartz et al, 1990; Decker, 1988).
    b) Patients at increased risk for development of prolonged sequelae were older and had marked airflow obstruction and air trapping immediately following exposure (Schwartz et al, 1990).
    c) CASE REPORT: A 3.5-month-old infant exposed to chlorine gas had wheezing and persistent airway obstruction as shown by pulmonary function testing for 1 year after exposure (Givan et al, 1989).
    d) CASE SERIES: Pulp mill workers who reported transient exposures to high levels of chlorine gas showed increased airflow obstruction on pulmonary function tests compared to controls (Kennedy et al, 1991).
    e) CASE SERIES: Bronchoscopy was performed on 28 patients 5 to 25 days after unintentional exposure to approximately 66 parts per million (ppm) of chlorine gas. Cytopathologic features of bronchial brushings included varying degrees of bronchial mucosal damage and acute inflammatory response. On day 15, bronchoscopy of 7 patients who had persistent cough and respiratory distress showed evidence of secondary bacterial invasion. Bronchoscopy of these same 7 patients on day 25 revealed evidence of repair by fibrosis (Shroff et al, 1988).
    f) CASE SERIES: Episodes of high chlorine gas exposure in pulp mill workers have been associated with evidence of obstructive disease on pulmonary function testing, decreasing FEV1/FVC over time, and self-reported respiratory symptoms (chest tightness, sputum production, wheezing, and cough) (Henneberger et al, 1996; Salisbury et al, 1991). Most of these workers were also exposed to other irritant gases (Salisbury et al, 1991).
    1) Heavy smoking appears to have a synergistic effect on the development of obstructive pulmonary disease in chlorine-exposed workers (Henneberger et al, 1996).
    g) CASE SERIES: In a population of 113 people who were exposed to chlorine gas following a train derailment, the probability of having been admitted to the hospital after the initial exposure was related to the person's distance from the spill. Three weeks after exposure there was no detectable difference in lung function that could be related to distance from the spill or initial severity of injury (Jones et al, 1986).
    1) Sixty of these patients were monitored for 6 years with pulmonary function tests (PFTs). These was no detectable change in PFT results related to severity of chlorine exposure. None of these patients had pulmonary evaluations prior to the spill, so an initial permanent change in pulmonary function could not be detected.
    h) CASE SERIES: Following a train derailment that released 42 to 60 tons of chlorine gas within a small town, 63 patients were hospitalized on the day of the accident. All of the patients presented with at least 1 pulmonary complaint, with wheezing being the most common immediate/persistent physical pulmonary finding (46%). Other respiratory findings included rales/crackles, cough, decreased breath sounds, rhonchi, labored breathing, retractions, and tachypnea. Of those findings, the most prevalent delayed sign was rales/crackles, occurring in 18 of the 71 patients (29%) (Van Sickle et al, 2009).
    M) SEQUELA
    1) WITH POISONING/EXPOSURE
    a) The long-term effects of acute chlorine exposure on pulmonary function have been debated in the literature. A historical study suggested a lack of permanent effect (Weill et al, 1969), while current findings include persistent pulmonary abnormalities (eg, a decrease in total lung capacity, functional residual capacity, and vital capacity and a significant increase in residual volume and airway resistance over several years and persistent reactive airways dysfunction syndrome) (Williams, 1997; Deschamps et al, 1994; Demeter & Cordasco, 1992; Moore & Sherman, 1991).
    b) LONGITUDINAL STUDY
    1) Eighteen children, 6 to 12 years old, were exposed to chlorine gas after an excessive amount of chlorine was accidentally added to a swimming pool. A longitudinal study found acute severe pulmonary symptoms in the first week after exposure, with return to normal function within 15 days from the chlorine gas exposure. Low fractions of nitric oxide in exhaled air (FE(NO)) in exposed children, compared with healthy controls, were observed on admission and in the first few weeks following exposure. The fractions of nitric oxide in exhaled air reached normal values within 2 months. High exhaled breath condensate leukotriene B4 levels, which serve as a biomarker for neutrophilic inflammation, persisted for several months after exposure despite lack of respiratory symptoms. No exercise-induced bronchoconstriction was found during an exercise challenge at 8 months postexposure (Bonetto et al, 2006).
    c) REACTIVE AIRWAY DYSFUNCTION SYNDROME
    1) CASE SERIES: In a study of repeatedly exposed workers, 82% developed respiratory symptoms 18 to 24 months after last exposure; 41% had bronchial hyperresponsiveness, and 23% had FEV1 less than 80% of predicted (Bherer et al, 1994).
    d) INFLUENZA-LIKE SYMPTOMS
    1) Over 60% of workers who had multiple exposures to chlorine gas over a 3- to 6-month period developed throat and eye irritation, cough, headache, and shortness of breath (Courteau et al, 1994).

Neurologic

    3.7.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Headache may develop. Agitation and anxiety may develop in patients with significant respiratory compromise.
    3.7.2) CLINICAL EFFECTS
    A) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) Headache is the most frequently reported neurological complaint (Centers for Disease Control and Prevention (CDC), 2011; Courteau et al, 1994; CDC, 1991; Hedges & Morrissey, 1979).
    b) INCIDENCE: In a series of 281 workers who had been repeatedly exposed to chlorine, 63% complained of headache (Courteau et al, 1994). In another series of 82 workers, headache was reported in 24% to 29% of patients (Sexton & Pronchik, 1998).
    B) PSYCHOMOTOR AGITATION
    1) WITH POISONING/EXPOSURE
    a) Agitation and anxiety may develop in patients with significant respiratory compromise (Noe, 1963).
    C) CENTRAL NERVOUS SYSTEM DEFICIT
    1) WITH POISONING/EXPOSURE
    a) CNS depression ranging from lethargy to coma may develop in patients with severe pulmonary injury (Heidemann & Goetting, 1991).
    D) NEUROTOXICITY
    1) WITH POISONING/EXPOSURE
    a) The significant neurobehavioral findings reported in 97 patients after exposure to spilled chlorine and potassium cresylate compared with a referent population included differences in simple reaction time, balance with eyes closed, vocabulary score, and information. Forty-eight of 90 patients had abnormal visual quadrants in visual fields. At 3 years postexposure, additional findings included differences in choice reaction time, balance with eyes open, color errors, immediate and delayed verbal recall, Culture Fair Test results, fingertip number writing errors, and blink reflex latency (Kilburn, 2003).
    E) ISCHEMIC STROKE
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 74-year-old woman, with diabetes, presented to the emergency department profoundly hypoxic (oxygen saturation 50%) and comatose after inhaling fumes from the combination of sodium hypochloride and hypochloric acid. Examination of the patient revealed tachycardia, miosis, rales and rhonchi of the lungs, and a Glasgow Coma Scale score of 5. Laboratory data revealed respiratory acidosis and an elevated blood glucose level (946 mg/dL). An ECG demonstrated anterior superior hemiblock and loss of R-wave progression, and an elevation in her cardiac enzymes was noted, indicating a non-Q myocardial infarction. A brain CT scan initially detected no abnormalities except for slight edema; however, a repeat CT, performed 1 day later, revealed an infarct of the right middle cerebral artery and effacement of right sulci. Despite aggressive supportive care, the patient's condition continued to deteriorate and she died on hospital day 5 (Kose et al, 2009).

Gastrointestinal

    3.8.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Vomiting may occur following initial exposure.
    3.8.2) CLINICAL EFFECTS
    A) VOMITING
    1) WITH POISONING/EXPOSURE
    a) Salivation, nausea, retching, and vomiting are typical findings following exposure (Mohan et al, 2010; Harbison, 1998; CDC, 1991; Hryhorczuk, 1986).
    b) INCIDENCE: In a series of 82 individuals who were exposed to chlorine gas, 24% to 29% developed vomiting (Sexton & Pronchik, 1998).
    B) ABDOMINAL PAIN
    1) WITH POISONING/EXPOSURE
    a) INCIDENCE: In a series of 82 individuals who were exposed to chlorine gas, 24% to 29% developed abdominal pain (Sexton & Pronchik, 1998).

Acid-Base

    3.11.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Following severe exposure, metabolic acidosis secondary to hypoxemia may be noted.
    3.11.2) CLINICAL EFFECTS
    A) ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) Metabolic acidosis has been reported following severe (fatal) exposure to chlorine gas or trichloro-s-triazinetrione powder (Martinez & Long, 1995; Adelson & Kaufman, 1971) . The acidosis is probably due to poor peripheral tissue oxygenation secondary to severe hypoxemia. Metabolic acidosis with hyperchloremia has been reported (Szerlip & Singer, 1984).
    b) CASE SERIES: Following a train derailment that released 42 to 60 tons of chlorine gas within a small town, metabolic acidosis and respiratory acidosis were reported in 9 and 25 patients, respectively, of 55 patients who had an arterial blood gas measurement (Van Sickle et al, 2009).

Dermatologic

    3.14.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Dermal exposure may cause erythema, pain, irritation, and cutaneous burns.
    3.14.2) CLINICAL EFFECTS
    A) CHEMICAL BURN
    1) WITH POISONING/EXPOSURE
    a) Liquid chlorine may cause cutaneous burns. Gaseous chlorine will irritate the skin and may cause burns in high concentrations (Raffle et al, 1994; Anon, 1984).
    b) Severe dermal, ocular, and pulmonary burns developed in a man who was exposed to chlorine gas after he added water to a pail containing trichloro-s-triazinetrione; the mixture exploded (Hathaway et al, 1996; Martinez & Long, 1995).
    B) SKIN IRRITATION
    1) WITH POISONING/EXPOSURE
    a) In a retrospective review of 598 poison center chlorine cases, 248 cases (41.5%) involved exposure to tablets; 320 (53.5%), exposure to liquid chlorine; and the remainder, to both. Skin complaints were reported in 2.5% of patients (LoVecchio et al, 2005).

Endocrine

    3.16.2) CLINICAL EFFECTS
    A) HYPERGLYCEMIA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Hyperglycemia (blood glucose level 946 mg/dL) was reported in a 74-year-old diabetic woman after inhaling fumes from the combination of sodium hypochloride and hypochloric acid (Kose et al, 2009).

Reproductive

    3.20.1) SUMMARY
    A) Chlorine (as hypochlorite) is teratogenic in experimental animals. Evaluations of sperm morphology in murine experiments demonstrated the presence of mutations.
    3.20.2) TERATOGENICITY
    A) ANIMAL STUDIES
    1) CONGENITAL ANOMALY
    a) Chlorine (as hypochlorite) was teratogenic at 100 parts per million (ppm) when given to pregnant rats in their water (Meier, 1985). Biochemical and metabolic effects were observed in newborn rats (RTECS , 2000).
    3.20.3) EFFECTS IN PREGNANCY
    A) BIRTH WEIGHT SUBNORMAL
    1) Smaller body length and smaller cranial circumference were found in infants of Italian mothers who drank water that had been disinfected with chlorine dioxide or sodium hypochlorite. The presence of neonatal jaundice was almost twice as likely in infants whose mothers drank water treated with chlorine dioxide (Kanitz et al, 1996).
    2) In another study, drinking water disinfected with sodium hypochlorite was significantly associated with decreased gestational age, low birth weight, smaller body length, and smaller cranial circumference. Chlorine dioxide did not show these effects. No significant increases were seen for Down syndrome, childhood cancer, or neonatal mortality for either agent. This study did not have individual exposure estimates (Kallen & Robert, 2000).
    a) As a whole, these various studies relating exposure to chlorinated by-products in drinking water with adverse human reproductive outcomes are very difficult to compare. They have examined different end points, have used different methods of dosimetry, and in any case dosimetry is very complex. Although the results are suggestive, they should be interpreted with caution (Reif et al, 1996).

Carcinogenicity

    3.21.1) IARC CATEGORY
    A) IARC Carcinogenicity Ratings for CAS7782-50-5 (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004):
    1) Not Listed
    3.21.2) SUMMARY/HUMAN
    A) Lymphoma has been observed in relation to water treatment with chlorine. Associations with increased renal, bladder, and gastric cancers have also been found, but firm conclusions cannot be drawn because of mixed exposures with caustic acids.
    3.21.3) HUMAN STUDIES
    A) LYMPHOMA-LIKE DISORDER
    1) Exposure to drinking water that had been disinfected with chlorine was associated with an increased risk of lymphoma, compared with exposure to chloramine-treated water, in a case-control study (Zierler et al, 1988).
    B) CARCINOMA
    1) Chlorine has been cited within the NTP Carcinogenesis Studies in a 2-year study (RTECS , 2000).
    C) RENAL CARCINOMA
    1) A retrospective mortality study on persons working in a chemical plant found 3.8-fold increased deaths from renal (kidney) cancer in persons who had worked in chlorine production. These persons had been exposed to caustic acids and hydrochloric acid as well as chlorine. Firm conclusions about chlorine as a possible human carcinogen cannot be drawn from this single study because of the mixed exposures (Bond et al, 1985).
    D) GASTRIC CARCINOMA
    1) Excess colon cancer rates have been found in some regions where hydrocarbons are present at high levels in chlorinated drinking water (Kanarek & Young, 1982).
    E) BLADDER CARCINOMA
    1) In a meta-analysis of 10 studies examining the relationship between chlorinated drinking water and cancer, there was an association between consumption of chlorinated by-products and cancer of the bladder and rectum (Morris et al, 1992).
    2) A weak association between occupational exposure to chlorine and risk of bladder cancer was seen in a cohort of 484 persons (compared with 1879 controls) in Montreal, Quebec, Canada, between 1979 and 1986. Firm conclusions about chlorine as a possible human carcinogen cannot be drawn from this single study because of mixed exposures (Siemiatycki et al, 1994).
    3.21.4) ANIMAL STUDIES
    A) CARCINOMA
    1) Chlorine gas was not carcinogenic in mice and rats that were exposed to concentrations up to 2.5 parts per million for 6 hours per day, 5 days per week for 2 years (Wolf et al, 1995). Chlorine administered in drinking water (as chlorine and sodium hypochlorite) produced lymphomas, leukemia, or both in rats, but it was not carcinogenic in a third study (Winder, 2001).

Genotoxicity

    A) Haloacetonitriles have produced DNA strand breaks in cultured human cells. Mutations have been detected in S typhimurium, and chromosome aberrations have been detected in human lymphocytes.

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Obtain a chest radiograph and monitor pulse oximetry in patients with respiratory distress.
    B) Obtain arterial blood gases in patients with severe respiratory distress.
    4.1.2) SERUM/BLOOD
    A) SPECIFIC AGENT
    1) Chlorine is generally not measurable since it converts directly to hydrochloric acid in the lungs and in the tissues.
    B) ACID/BASE
    1) Obtain a baseline pulse oximetry reading along with continuous monitoring as indicated.
    2) Obtain a baseline arterial blood gas in patients with hypoxia or significant dyspnea. Repeat as necessary.
    4.1.4) OTHER
    A) OTHER
    1) PULMONARY FUNCTION TESTS
    a) Recurrent respiratory symptoms should be evaluated by pulmonary function testing, although it is not indicated in the immediate exposure period (Traub et al, 2002).
    b) Persistent abnormalities have been noted on pulmonary function tests for up to 12 years after acute exposures (Schwartz et al, 1990).
    c) Eighteen children, ages 6 to 12 years, were exposed to chlorine gas after an excessive amount of chlorine was accidentally added to a swimming pool. Acutely, all children had respiratory symptoms and reduced lung function as determined by FVC and FEV1, low fractions of nitric oxide in exhaled air (FE(NO)), and high exhaled breath condensate leukotriene B4 levels. Lung function returned to normal within 15 days for all the children. The fractions of nitric oxide in exhaled air reached normal values within 2 months, and the exhaled breath condensate leukotriene B4 levels progressively declined over 8 months (Bonetto et al, 2006).
    d) Eighty-four school children who lived near a chemical plant that had a chlorine gas leak underwent pulmonary function testing 2 weeks after exposure. Compared with a control group, the exposed children had statistically significant decreases in mean values for VC, FVC, FEV1, PEFR, and V75. Overall evaluation of their pulmonary function tests revealed that 20 of the 84 children (24%) had a normal pattern, 56 (66%) had an obstructive pattern, and 8 (10%) had a restrictive pattern (Pherwani et al, 1989).
    e) Respiratory symptoms after exposure to chlorine gas were more common and more likely to be present at 15 to 30 days after the exposure in patients with chronic respiratory diseases and smokers or ex-smokers. Effects of exposure on lung function tended to be higher in smokers and ex-smokers (Agabiti et al, 2001).

Radiographic Studies

    A) CHEST RADIOGRAPH
    1) If respiratory signs and symptoms are present, obtain chest x-ray.

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.3) DISPOSITION/INHALATION EXPOSURE
    6.3.3.1) ADMISSION CRITERIA/INHALATION
    A) Patients with persistent respiratory symptoms after 4 to 6 hours should be admitted. Patients with severe respiratory distress or upper airway injury should be admitted to an intensive care unit.
    B) In a 5-year retrospective review598 home chlorine exposures reported to poison control centers, inclusion criteria consisted of self-reported exposure to "chlorine" liquid (10% or higher concentration of sodium hypochlorite) or tablet (90% or higher concentration). The most common complaints were cough (70%), shortness of breath (38%), nasal irritation (9.7%), eye irritation (8.5%), and skin irritation (2.5%), with most symptoms resolving within 24 hours. Hospitalization was required in 5 patients, with 4 of the patients having a history of reactive airway disease. All 5 patients were discharged within 48 hours, and all other patients remained clinically well at 24-hour telephone follow-up. Hospitalization is usually not required for a home exposure. Individuals with a history of reactive airway disease may be at increased risk (LoVecchio et al, 2002).
    6.3.3.2) HOME CRITERIA/INHALATION
    A) Patients who are asymptomatic and those who have mild, transient irritation (eye, skin, or respiratory) may be observed at home.
    B) In retrospective study of 216 patients who were exposed to chlorine (62) or chloramine (154) gases from mixing hypochlorites with acids or alkalies, 145 patients did not have severe respiratory distress and were successfully treated at home with fresh air, cool liquids, and general comfort measures. Telephone follow-up was performed at 30 to 60 minutes and 3 to 6 hours (Mrvos et al, 1993).
    6.3.3.3) CONSULT CRITERIA/INHALATION
    A) Consult critical care personnel if patient exhibits severe and protracted respiratory distress.
    B) Consult an ophthalmologist for patients with ocular burns.
    C) Consult a medical toxicologist or poison center for patients with persistent symptoms.
    6.3.3.5) OBSERVATION CRITERIA/INHALATION
    A) Patients with more than transient eye or pulmonary irritation should be sent to a healthcare facility for treatment and observation.
    B) If a patient requires medical treatment following chlorine gas exposure, patients can be discharged to home after a 6-hour observation period if pulse oximetry and chest radiograph results are normal. Patients with moderate to severe respiratory signs (abnormal oxygenation or ventilation) and symptoms should be admitted for further care (Traub et al, 2002).

Monitoring

    A) Obtain a chest radiograph and monitor pulse oximetry in patients with respiratory distress.
    B) Obtain arterial blood gases in patients with severe respiratory distress.

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) SUMMARY: Remove the patient from the contaminated environment as rapidly as possible. Make sure that rescuers are wearing self-contained breathing apparatus (SCBA) and have protective clothing.
    B) Move patient from the toxic environment to fresh air. Monitor for respiratory distress. If cough or difficulty in breathing develops, evaluate for hypoxia, respiratory tract irritation, bronchitis, or pneumonitis.
    C) OBSERVATION: Carefully observe patients with inhalation exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
    D) INITIAL TREATMENT: Administer 100% humidified supplemental oxygen, perform endotracheal intubation and provide assisted ventilation as required. Administer inhaled beta-2 adrenergic agonists, if bronchospasm develops. Consider systemic corticosteroids in patients with significant bronchospasm (National Heart,Lung,and Blood Institute, 2007). Exposed skin and eyes should be flushed with copious amounts of water.
    E) If clothing is contaminated with chlorine, remove and wash skin with copious amounts of water.
    6.7.2) TREATMENT
    A) OXYGEN
    1) Initially, administer 100% humidified oxygen for short periods, then adjust oxygen concentration to the comfort of the patient. An oxygen saturation of 90% or greater is the usual goal of therapy.
    B) BRONCHOSPASM
    1) Laryngospasm or bronchospasm should be treated with bronchodilation with inhaled sympathomimetic agents. Humidified oxygen and beta-agonists were the most useful therapy of acute chlorine intoxications in a case series of 106 patients (Guloglu et al, 2002). Inhaled nebulized sodium bicarbonate may also be useful.
    2) ANIMAL DATA: In a randomized, controlled study, domestic juvenile female pigs were exposed to chlorine gas via a ventilator at a concentration of 400 ppm, and the effects of beta-2 adrenergic agonist (aerosolized terbutaline) and corticosteroid (budesonide) therapy were measured. The animals were divided into 4 treatment groups: aerosolized terbutaline alone, aerosolized budesonide alone, aerosolized terbutaline and budesonide, and a placebo group. Oxygenation and lung compliance improved in the terbutaline and the budesonide alone groups; however, the combination of aerosolized terbutaline and budesonide was the most effective in improving lung function (Wang et al, 2004).
    C) SODIUM BICARBONATE
    1) Theoretically, the use of sodium bicarbonate may neutralize the acidic products that are formed when the chlorine gas reacts with water (Traub et al, 2002).
    2) HUMAN
    a) A double-blind, placebo-controlled study was conducted to determine the efficacy of nebulized sodium bicarbonate for treatment of reactive airways dysfunction syndrome (RADS) following chlorine gas inhalation. Forty-four patients with persistent RADS for at least 3 months with initial onset within 24 hours of chlorine gas inhalation were given either nebulized sodium bicarbonate (n=22) or nebulized placebo (n=22). All patients also received corticosteroids and nebulized short-acting beta-agonists. FEV1 values were significantly higher at 120 and 240 minutes in the nebulized sodium bicarbonate group as compared with the nebulized placebo group (p less than 0.05). The quality of life scores in both groups, determined from questionnaires, also improved significantly following treatment (p less than 0.001), but there was no significant difference between the groups (Aslan et al, 2006).
    b) CASE REPORTS: Dramatic improvement of early respiratory symptoms was noted following humidification with a 5% sodium bicarbonate solution in an anecdotal report (Done, 1976) and with a 3.75% sodium bicarbonate solution in 3 male patients with mild symptoms in another anecdotal report (Vinsel, 1990).
    1) CASE REPORT/PEDIATRIC: A 7-year-old exposed to chlorine fumes showed immediate improvement in her respiratory symptoms after receiving a total concentration of 3.75% sodium bicarbonate solution via nebulizer. The solution was prepared by diluting 2 mL of the standard pediatric IV sodium bicarbonate solution (8.4%) with 2.25 mL of normal saline. A total of 4.25 mL was given over 20 minutes with resolution of symptoms; oxygen saturation remained between 96% and 100% on room air (Douidar, 1997).
    c) CASE SERIES: In a retrospective review of 86 cases of chlorine gas exposure that were treated with nebulized sodium bicarbonate (3 mL of 8.4% sodium bicarbonate mixed with 2 mL normal saline administered as a nebulizer treatment with oxygen or air), 69 patients were treated and released from the emergency department. Of these, 7 also received inhaled bronchodilators, 1 patient received steroids, 2 were discharged with bronchodilators, and 1 patient was discharged with a course of steroids. Condition was improved on discharge in 53 patients, 23 of whom were asymptomatic. Condition was not specified in 16 patients who were treated and released. Seventeen patients required hospital admission. No patient appeared to suffer an adverse effect that could be attributed to sodium bicarbonate (Bosse, 1994a).
    d) Steroid and bicarbonate treatments were inadequate supportive therapies for patients with acute chlorine intoxication in a case series of 106 patients (Guloglu et al, 2002).
    e) Clinically, humidification with 5% sodium bicarbonate does not seem to produce a notable thermal reaction within the lung parenchyma. This most likely occurs due to the dilute concentration used.
    3) ANIMAL DATA
    a) A study in sheep that were exposed to chlorine gas for 4 minutes and then randomized to receive 8 mL of nebulized normal saline or 4% sodium bicarbonate demonstrated a higher PCO2 and lower PO2 in the control group. Sodium bicarbonate did not worsen outcome, as measured by mortality and postmortem pathologic evaluation, and appeared to improve arterial blood gas values (Chisholm et al, 1989).
    4) PREPARATION: A 3.75% solution of sodium bicarbonate can be prepared by diluting 2 mL of the standard 7.5% sodium bicarbonate intravenous solution with 2 mL normal saline (Vinsel, 1990).
    D) MONITORING OF PATIENT
    1) Obtain a chest radiograph and monitor pulse oximetry in patients with respiratory distress. Obtain arterial blood gases in patients with severe respiratory distress.
    2) Monitor respiratory function for several hours to assure that acute lung injury does not develop. Respiratory findings may be delayed up to a few hours (Lawson, 1981). Diminished pulmonary function test results have been reported for FEV1, FEF 25% to 75%, FEF 50%, and FEF 25% (Hasan et al, 1983).
    3) Respiratory failure that requires mechanical ventilation indicates a poorer prognosis (Hryhorczuk, 1986).
    4) Respiratory monitoring is recommended until the patient is symptom-free; 7 cases of reactive airways dysfunction syndrome (RADS) persisting for 2 to 12 years after an acute chlorine gas exposure have been reported (Schwartz et al, 1990; Decker, 1988).
    E) BURN OF SKIN OF BODY REGION
    1) Examination of mucous membranes, eyes, and skin should be performed to be sure that caustic injury has not occurred (Anon, 1984).
    F) ACUTE LUNG INJURY
    1) ONSET: Onset of acute lung injury after toxic exposure may be delayed up to 24 to 72 hours after exposure in some cases.
    2) NON-PHARMACOLOGIC TREATMENT: The treatment of acute lung injury is primarily supportive (Cataletto, 2012). Maintain adequate ventilation and oxygenation with frequent monitoring of arterial blood gases and/or pulse oximetry. If a high FIO2 is required to maintain adequate oxygenation, mechanical ventilation and positive-end-expiratory pressure (PEEP) may be required; ventilation with small tidal volumes (6 mL/kg) is preferred if ARDS develops (Haas, 2011; Stolbach & Hoffman, 2011).
    a) To minimize barotrauma and other complications, use the lowest amount of PEEP possible while maintaining adequate oxygenation. Use of smaller tidal volumes (6 mL/kg) and lower plateau pressures (30 cm water or less) has been associated with decreased mortality and more rapid weaning from mechanical ventilation in patients with ARDS (Brower et al, 2000). More treatment information may be obtained from ARDS Clinical Network website, NIH NHLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary, http://www.ardsnet.org/node/77791 (NHLBI ARDS Network, 2008)
    3) FLUIDS: Crystalloid solutions must be administered judiciously. Pulmonary artery monitoring may help. In general the pulmonary artery wedge pressure should be kept relatively low while still maintaining adequate cardiac output, blood pressure and urine output (Stolbach & Hoffman, 2011).
    4) ANTIBIOTICS: Indicated only when there is evidence of infection (Artigas et al, 1998).
    5) EXPERIMENTAL THERAPY: Partial liquid ventilation has shown promise in preliminary studies (Kollef & Schuster, 1995).
    6) CALFACTANT: In a multicenter, randomized, blinded trial, endotracheal instillation of 2 doses of 80 mL/m(2) calfactant (35 mg/mL of phospholipid suspension in saline) in infants, children, and adolescents with acute lung injury resulted in acute improvement in oxygenation and lower mortality; however, no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was noted. Adverse effects (transient hypoxia and hypotension) were more frequent in calfactant patients, but these effects were mild and did not require withdrawal from the study (Wilson et al, 2005).
    7) However, in a multicenter, randomized, controlled, and masked trial, endotracheal instillation of up to 3 doses of calfactant (30 mg) in adults only with acute lung injury/ARDS due to direct lung injury was not associated with improved oxygenation and longer term benefits compared to the placebo group. It was also associated with significant increases in hypoxia and hypotension (Willson et al, 2015).
    G) CORTICOSTEROID
    1) Although animal models suggest that corticosteroids can hasten recovery from severe chlorine gas poisoning (Traub et al, 2002), administration of steroids to exposed patients (Flete et al, 1986; Chester et al, 1977)), has not been shown to provide any significant change in the course of chlorine gas poisoning (Hryhorczuk, 1986).
    2) ANIMAL DATA: In a randomized, controlled study, domestic juvenile female pigs were exposed to chlorine gas via a ventilator at a concentration of 400 ppm, and the effects of beta-2 adrenergic agonist (aerosolized terbutaline) and corticosteroid (budesonide) therapy were measured. The animals were divided into 4 treatment groups: aerosolized terbutaline alone, aerosolized budesonide alone, aerosolized terbutaline and budesonide, and a placebo group. Oxygenation and lung compliance improved in the terbutaline and the budesonide alone groups; however, the combination of aerosolized terbutaline and budesonide the was most effective in improving lung function (Wang et al, 2004).
    3) Steroid and bicarbonate treatments were inadequate supportive therapy for patients with acute chlorine intoxication in a case series of 106 patients (Guloglu et al, 2002).
    H) VENTRICULAR ARRHYTHMIA
    1) Except for severe cases, (Edwards et al, 1983) dysrhythmias are rare. Antidysrhythmics should be considered, however, if cardiac monitoring exposes a serious arrhythmia.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).
    6.8.2) TREATMENT
    A) IRRITATION SYMPTOM
    1) Conjunctival irritation should be evaluated for corneal defects by an examination using fluorescein (Anon, 1984).

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DERMAL DECONTAMINATION
    1) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    6.9.2) TREATMENT
    A) GENERAL TREATMENT
    1) Treatment should include recommendations listed in the INHALATION EXPOSURE section when appropriate.

Case Reports

    A) ADVERSE EFFECTS
    1) Two workers in the immediate vicinity of a chlorine gas leak from a 150-pound cylinder experienced tightness of the chest and lacrimation; 10 others reported dizziness, burning nostrils, lacrimation, and lightheadedness (Maddy & Edmiston, 1988).

Summary

    A) The range of toxicity depends on the concentration of chlorine gas, duration of exposure, water content of the tissues exposed, physical location of exposure (eg, enclosed space), and individual susceptibility. It has been estimated that at 1 to 3 parts per million (ppm) mild mucous membrane irritation can occur; 5 to 15 ppm will cause moderate irritation of the upper respiratory tract; and 30 ppm will produce immediate chest pain, vomiting, dyspnea, and cough. Exposure to concentrations of 35 to 51 ppm are lethal in 60 to 90 minutes, and 1000 ppm is lethal within a few minutes.
    B) The OSHA time-weighted average permissible exposure limit (TWA PEL) is 1 ppm, and the NIOSH immediately dangerous to life and health (IDLH) level is 10 ppm.
    C) One or two breaths of gas accumulating above swimming pool or spa chlorinator tablets may cause marked respiratory distress and hypoxemia.

Minimum Lethal Exposure

    A) ACUTE
    1) It has been estimated that at 1 to 3 parts per million (ppm) mild mucous membrane irritation can occur; 5 to 15 ppm will cause moderate irritation of the upper respiratory tract; and 30 ppm will produce immediate chest pain, vomiting, dyspnea and cough. Exposures greater than or equal to 430 ppm chlorine for 30 minutes can be fatal to humans, as can exposures of 34 to 51 ppm for durations of 1 to 1.5 hours (Bingham et al, 2001). It should be noted that some individuals with airway hyperresponsiveness may develop an exaggerated response to even low levels of chlorine (Bingham et al, 2001). In a small study of 6 chlorine-exposed (range of exposure: 30 minutes to 12 hours) workers, it was observed that the development of reactive airway dysfunction syndrome appears unpredictable (Hickmann et al, 2001).
    2) LCLo values for human inhalation exposure of 2530 mg/m(3) for 30 minutes and 500 ppm for 5 minutes (RTECS , 2001).
    3) A few minutes or a few deep breaths of a level of 1000 ppm is fatal (Bingham et al, 2001; Hathaway et al, 1996; Sittig, 1991).

Maximum Tolerated Exposure

    A) CONCENTRATION LEVEL
    1) Chlorine at concentrations at or below 1 parts per million (ppm), which is usually more than is generated in home exposures, has minimal effects. Exposure to sublethal amounts may lead to significant residual lung damage. Restrictive lung defects resolved within 1 month in 4 patients (Ploysongsang et al, 1982), but long-term effects have been reported (Schwartz et al, 1990; Givan et al, 1989; Decker, 1988) .
    2) Industrial incidents involving several exposures to chlorine may have delayed-onset pulmonary symptoms. It is possible for a person to be asymptomatic on the first evaluation. Acute lung injury and congestion can develop several hours after the exposure (Bingham et al, 2001).
    3) One or two breaths of gas accumulating above swimming pool or spa chlorinator tablets has caused marked respiratory distress and hypoxemia in children (Wood et al, 1987).
    4) Exposure to more than 14 ppm for 30 minutes or more may result in severe pulmonary damage (Bingham et al, 2001).
    5) Based on the results of a study in 29 men and women, a 2-part standard has been recommended: chlorine concentrations of 0.5 ppm, averaged over 8 hours, should not exceed 2 ppm for any 15-minute period. The study included both smokers and nonsmokers who were exposed to 0, 0.5, 1, or 2 ppm of chlorine over 4- and 8-hour time frames (Bingham et al, 2001; ACGIH, 1991).
    B) EFFECTS OF EXPOSURE LEVELS (HSDB , 2001; Lewis, 2000; Harbison, 1998; Ellenhorn & Barceloux, 1988):
    0.2 to 3.5 ppmOdor detection (some tolerance develops)
    1 to 3 ppmMild mucous membrane irritation that can be tolerated for up to 1 hour
    3 ppmExtremely irritating to the eyes and respiratory tract
    5 ppmSevere irritation of eyes, nose, and respiratory tract; intolerable after a few minutes
    14 to 21 ppmImmediate irritation of the throat; dangerous if exposed for 30 to 60 minutes
    15 ppmIrritation of the throat
    30 ppmModerate irritation of the upper respiratory tract; Immediate chest pain, vomiting, dyspnea, cough
    35 to 50 ppmLethal in 60 to 90 minutes
    40 to 60 ppmToxic pneumonitis and acute lung injury; dangerous for even short periods
    430 ppmLethal over 30 minutes
    1000 ppmFatal within a few minutes

    C) NIOSH considers 10 parts per million (ppm) immediately dangerous to life or health (NIOSH , 2001).

Workplace Standards

    A) ACGIH TLV Values for CAS7782-50-5 (American Conference of Governmental Industrial Hygienists, 2010):
    1) Editor's Note: The listed values are recommendations or guidelines developed by ACGIH(R) to assist in the control of health hazards. They should only be used, interpreted and applied by individuals trained in industrial hygiene. Before applying these values, it is imperative to read the introduction to each section in the current TLVs(R) and BEI(R) Book and become familiar with the constraints and limitations to their use. Always consult the Documentation of the TLVs(R) and BEIs(R) before applying these recommendations and guidelines.
    a) Adopted Value
    1) Chlorine
    a) TLV:
    1) TLV-TWA: 0.5 ppm
    2) TLV-STEL: 1 ppm
    3) TLV-Ceiling:
    b) Notations and Endnotes:
    1) Carcinogenicity Category: A4
    2) Codes: Not Listed
    3) Definitions:
    a) A4: Not Classifiable as a Human Carcinogen: Agents which cause concern that they could be carcinogenic for humans but which cannot be assessed conclusively because of a lack of data. In vitro or animal studies do not provide indications of carcinogenicity which are sufficient to classify the agent into one of the other categories.
    c) TLV Basis - Critical Effect(s): URT and eye irr
    d) Molecular Weight: 70.91
    1) For gases and vapors, to convert the TLV from ppm to mg/m(3):
    a) [(TLV in ppm)(gram molecular weight of substance)]/24.45
    2) For gases and vapors, to convert the TLV from mg/m(3) to ppm:
    a) [(TLV in mg/m(3))(24.45)]/gram molecular weight of substance
    e) Additional information:
    b) Under Study
    1) Chlorine
    a) TLV:
    1) TLV-TWA:
    2) TLV-STEL:
    3) TLV-Ceiling:
    b) Notations and Endnotes:
    1) Carcinogenicity Category: Not Listed
    2) Codes: Not Listed
    3) Definitions: Not Listed
    c) TLV Basis - Critical Effect(s):
    d) Molecular Weight:
    1) For gases and vapors, to convert the TLV from ppm to mg/m(3):
    a) [(TLV in ppm)(gram molecular weight of substance)]/24.45
    2) For gases and vapors, to convert the TLV from mg/m(3) to ppm:
    a) [(TLV in mg/m(3))(24.45)]/gram molecular weight of substance
    e) Additional information:

    B) NIOSH REL and IDLH Values for CAS7782-50-5 (National Institute for Occupational Safety and Health, 2007):
    1) Listed as: Chlorine
    2) REL:
    a) TWA:
    b) STEL:
    c) Ceiling: 0.5 ppm (1.45 mg/m(3)) [15-minute]
    d) Carcinogen Listing: (Not Listed) Not Listed
    e) Skin Designation: Not Listed
    f) Note(s):
    3) IDLH:
    a) IDLH: 10 ppm
    b) Note(s): Not Listed

    C) Carcinogenicity Ratings for CAS7782-50-5 :
    1) ACGIH (American Conference of Governmental Industrial Hygienists, 2010): A4 ; Listed as: Chlorine
    a) A4 :Not Classifiable as a Human Carcinogen: Agents which cause concern that they could be carcinogenic for humans but which cannot be assessed conclusively because of a lack of data. In vitro or animal studies do not provide indications of carcinogenicity which are sufficient to classify the agent into one of the other categories.
    2) ACGIH (American Conference of Governmental Industrial Hygienists, 2010): Not Listed ; Listed as: Chlorine
    3) EPA (U.S. Environmental Protection Agency, 2011): Not Assessed under the IRIS program. ; Listed as: Chlorine
    4) IARC (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004): Not Listed
    5) NIOSH (National Institute for Occupational Safety and Health, 2007): Not Listed ; Listed as: Chlorine
    6) MAK (DFG, 2002): Not Listed
    7) NTP (U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project ): Not Listed

    D) OSHA PEL Values for CAS7782-50-5 (U.S. Occupational Safety, and Health Administration (OSHA), 2010):
    1) Listed as: Chlorine
    2) Table Z-1 for Chlorine:
    a) 8-hour TWA:
    1) ppm: 1
    a) Parts of vapor or gas per million parts of contaminated air by volume at 25 degrees C and 760 torr.
    2) mg/m3: 3
    a) Milligrams of substances per cubic meter of air. When entry is in this column only, the value is exact; when listed with a ppm entry, it is approximate.
    3) Ceiling Value: (C) - An employee's exposure to this substance shall at no time exceed the exposure limit given.
    4) Skin Designation: No
    5) Notation(s): Not Listed

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) References: ITI, 1995; Lewis, 2000; RTECS, 2001
    1) TCLo- (INHALATION)HUMAN:
    a) 66 ppm for 1H - cough and dyspnea; headache
    b) 500 ppb for 2D-intermittent -- tolerance behavior affected
    2) TCLo- (INHALATION)MOUSE:
    a) 400 ppb for 6H/2Y-intermittent -- changes to nose, eyes, ears, and taste
    b) 9100 ppb/for 6H/5D- intermittent -- decreased weight gain and weight loss; changes to sense organs; structural and functional changes to trachea or bronchi
    3) TCLo- (INHALATION)RAT:
    a) 400 ppb for 6H/2Y-intermittent-- changes to the sense organs
    b) 9 ppm for 6H/6W-intermittent-- changes to white blood count, phosphatases, kidney, bladder, and ureter
    c) 9100 ppb for 6H/5D-intermittent -- decreased weight gain or weight loss; changes to the sense organs; structural or functional changes to bronchi or trachea

Toxicologic Mechanism

    A) Chlorine gas in concentrated amounts may be caustic to mucous membranes when inhaled or ingested; otherwise, it is a strong irritant. Caustic injury is NOT likely with the amounts liberated in unintentional home production. It is more likely to occur with a ruptured or opened industrial tank or container. On contact with moist tissue, nascent oxygen or "active oxygen" is released when hydrogen is removed from H2O. Nascent oxygen is a potent oxidizer, resulting in tissue damage. Secondary irritation occurs from acids formed during this reaction.
    B) Contact with respiratory epithelium produces initial alveolar capillary congestion followed by focal and confluent patches of high fibrinogen edematous fluid.
    C) Acute lung injury peaks in 12 to 24 hours. The fluid is interstitial at first but can fill the alveoli. Once this occurs, copious frothy, blood-tinged sputum can be observed.
    D) Several hours after inhalation, granulocyte response can occur. Hyaline membrane formation can occur later resulting in clinical deterioration at a time when signs of improvement have occurred. Poor oxygen diffusion, hypoxemia, and hypercapnia result from development of atelectasis, emphysema, and membrane formation. The PO2 is low on 100% oxygen and the PCO2 rises rapidly. Respiratory acidosis and lactic acidosis result. Death usually occurs from cardiac arrest due to intractable hypoxia (Decker & Koch, 1978).

Physical Characteristics

    A) Chlorine is a greenish-yellow diatomic gas with an irritating, pungent, or suffocating odor (Budavari, 2000; Lewis, 1997; NIOSH , 2001).
    B) It condenses to an clear amber liquid at minus 35 degrees C and may also take the form of rhombic crystals (ACGIH, 1991; Lewis, 1997).

Molecular Weight

    A) 70.9

General Bibliography

    1) 40 CFR 372.28: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Lower thresholds for chemicals of special concern. National Archives and Records Administration (NARA) and the Government Printing Office (GPO). Washington, DC. Final rules current as of Apr 3, 2006.
    2) 40 CFR 372.65: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Chemicals and Chemical Categories to which this part applies. National Archives and Records Association (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Apr 3, 2006.
    3) 49 CFR 172.101 - App. B: Department of Transportation - Table of Hazardous Materials, Appendix B: List of Marine Pollutants. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 29, 2005.
    4) 49 CFR 172.101: Department of Transportation - Table of Hazardous Materials. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 11, 2005.
    5) 62 FR 58840: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 1997.
    6) 65 FR 14186: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    7) 65 FR 39264: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    8) 65 FR 77866: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    9) 66 FR 21940: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2001.
    10) 67 FR 7164: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2002.
    11) 68 FR 42710: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2003.
    12) 69 FR 54144: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2004.
    13) AAR: Emergency Handling of Hazardous Materials in Surface Transportation, Bureau of Explosives, Association of American Railroads, Washington, DC, 2000.
    14) ACGIH: Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th ed, Am Conference of Govt Ind Hyg, Inc, Cincinnati, OH, 1991.
    15) AIHA: 2006 Emergency Response Planning Guidelines and Workplace Environmental Exposure Level Guides Handbook, American Industrial Hygiene Association, Fairfax, VA, 2006.
    16) Abhyankar A, Bhambure N, & Kamath NN: Six month follow-up of fourteen victims with short-term exposure to chlorine gas. J Soc Occup Med 1989; 39:131-132.
    17) Adelson L & Kaufman J: Fatal chlorine poisoning. Report of two cases with clinicopathologic correlation. Am J Clin Pathol 1971; 56:430-442.
    18) Agabiti N, Ancona C, & Forastiere F: Short term respiratory effects of acute exposure to chlorine due to a swimming pool accident. Occup Environ Med 2001; 58:399-404.
    19) Akdur O, Durukan P, Ikizceli I, et al: A rare complication of chlorine gas inhalation: pneumomediastinum. Emerg Med J 2006; 23(11):e59-.
    20) American Conference of Governmental Industrial Hygienists : ACGIH 2010 Threshold Limit Values (TLVs(R)) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs(R)), American Conference of Governmental Industrial Hygienists, Cincinnati, OH, 2010.
    21) Anon: Chlorine poisoning. Lancet 1984; 1:321.
    22) Ansell-Edmont: SpecWare Chemical Application and Recommendation Guide. Ansell-Edmont. Coshocton, OH. 2001. Available from URL: http://www.ansellpro.com/specware. As accessed 10/31/2001.
    23) Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347.
    24) Ashford R: Ashford's Dictionary of Industrial Chemicals, Wavelength Publications Ltd, London, England, 1994.
    25) Aslan S, Kandis H, Akgun M, et al: The effect of nebulized NaHCO3 treatment on "RADS" due to chlorine gas inhalation. Inhal Toxicol 2006; 18(11):895-900.
    26) Barrett JBD: Green hair. JAMA 1977; 238:1722.
    27) Bata Shoe Company: Industrial Footwear Catalog, Bata Shoe Company, Belcamp, MD, 1995.
    28) Benjamin E & Pickles J: Chlorine-induced anosmia. A case presentation. J Laryngol Otol 1997; 111:1075-1076.
    29) Best Manufacturing: ChemRest Chemical Resistance Guide. Best Manufacturing. Menlo, GA. 2002. Available from URL: http://www.chemrest.com. As accessed 10/8/2002.
    30) Best Manufacturing: Degradation and Permeation Data. Best Manufacturing. Menlo, GA. 2004. Available from URL: http://www.chemrest.com/DomesticPrep2/. As accessed 04/09/2004.
    31) Bherer L, Cushman R, & Courteau JP: Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill. II. Follow up of affected workers by questionnaire, spirometry, and assessment of bronchial responsiveness 18 to 24 months after exposure ended. Occup Environ Medicine 1994; 51:225-228.
    32) Bingham E, Chorssen B, & Powell CH: Patty's Toxicology, Vol 3. 5th ed, John Wiley & Sons, New York, NY, 2001.
    33) Bond GG, Shellenberger RJ, & Flores GH: A case-control study of renal cancer mortality at a Texas chemical plant. Am J Ind Med 1985; 7:123-139.
    34) Bonetto G, Corradi M, Carraro S, et al: Longitudinal monitoring of lung injury in children after acute chlorine exposure in a swimming pool. Am J Respir Crit Care Med 2006; 174(5):545-549.
    35) Boss Manufacturing Company: Work Gloves, Boss Manufacturing Company, Kewanee, IL, 1998.
    36) Bosse GM: Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. Clin Toxicol 1994; 32:233-241.
    37) Bosse GM: Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. J Toxicol Clin Toxicol 1994a; 32(3):233-241.
    38) Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308.
    39) Budavari S: The Merck Index, 12th ed. on CD-ROM. Version 12:3a. Chapman & Hall/CRCnetBASE. Whitehouse Station, NJ. 2000.
    40) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    41) CDC: Chlorine gas toxicity from mixture of bleach with other cleaning products -- California. CDC: MMRW 1991; 40:619-629.
    42) CGA: Handbook of Compressed Gases, 3rd ed, Compressed Gas Association, Inc, Van Nostrand Reinhold, Inc, New York, NY, 1990.
    43) CGA: Handbook of Compressed Gases, 3rd ed, Compressed Gas Association, Inc, Van Nostrand Reinhold, New York, NY, 1999a.
    44) CGA: Handbook of Compressed Gases, 4th ed, Compressed Gas Association, Inc, Van Nostrand Reinhold, Inc, New York, NY, 1999.
    45) CGA: Handbook of Compressed Gases, 4th ed, Compressed Gas Association, Inc, Van Nostrand Reinhold, New York, NY, 1999b.
    46) CHRIS : CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard. Washington, DC (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    47) Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012.
    48) Centers for Disease Control and Prevention (CDC): Chlorine gas exposure at a metal recycling facility--California, 2010. MMWR Morb Mortal Wkly Rep 2011; 60(28):951-954.
    49) Centerwall BS, Armstrong CW, & Funkhouser LS: Erosion of dental enamel among competitive swimmers at a gas-chlorinated swimming pool. Am J Epidemiol 1986; 123:641-647.
    50) ChemFab Corporation: Chemical Permeation Guide Challenge Protective Clothing Fabrics, ChemFab Corporation, Merrimack, NH, 1993.
    51) Chester EH, Kaimal J, & Payne CB: Pulmonary injury following exposure to chlorine gas. Possible beneficial effects of steroid treatment. Chest 1977; 72:247-250.
    52) Chisholm CD, Singletary EM, & Okerberg CV: Inhaled sodium bicarbonate therapy for chlorine inhalation injuries (Abstract). Ann Emerg Med 1989; 18:466.
    53) Clayton GD & Clayton FE: Patty's Industrial Hygiene and Toxicology, Vol 2F, Toxicology, 4th ed, John Wiley & Sons, New York, NY, 1994, pp 4482-4505.
    54) Comasec Safety, Inc.: Chemical Resistance to Permeation Chart. Comasec Safety, Inc.. Enfield, CT. 2003. Available from URL: http://www.comasec.com/webcomasec/english/catalogue/mtabgb.html. As accessed 4/28/2003.
    55) Comasec Safety, Inc.: Product Literature, Comasec Safety, Inc., Enfield, CT, 2003a.
    56) Cooper R & Goodman J: Green hair. N Engl J Med 1975; 292:483-484.
    57) Courteau JP, Cushman R, & Bouchard F: Survey of construction workers repeatedly exposed to chlorine over a three to six month period in a pulpmill. 1. Exposure and symptomatology. Occup Environ Medicine 1994; 51:219-224.
    58) D'Alessandro A, Kuschner W, & Wong H: Exaggerated responses to chlorine inhalation among persons with nonspecific airway hyperreactivity. Chest 1996; 109:331-337.
    59) DFG: List of MAK and BAT Values 2002, Report No. 38, Deutsche Forschungsgemeinschaft, Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Wiley-VCH, Weinheim, Federal Republic of Germany, 2002.
    60) Daniel FB, Schenck KM, & Mattox JK: Genotoxic properties of haloacetonitriles: drinking water by-products of chlorine disinfection. Fundam Appl Toxicol 1986; 6:447-453.
    61) Das R & Blanc PD: Chlorine gas exposure and the lung: a review. Toxicol Ind.Health 1993; 9(3):439-455.
    62) Decker WJ & Koch HF: Chlorine poisoning at the swimming pool: an overlooked hazard. Clin Toxicol 1978; 13:377-381.
    63) Decker WJ: Reactive airways dysfunction syndrome following a single acute exposure to chlorine gas (Abstract). Vet Human Toxicol 1988; 30:344.
    64) Demeter SL & Cordasco EW: Reactive airway disease after chlorine gas exposure. Chest 1992; 102:984.
    65) Deschamps D, Soler P, & Rosenberg N: Persistent asthma after inhalation of a mixture of sodium hypochlorite and hydrochloric acid. Chest 1994; 105:1895-1896.
    66) Done AK: The toxic emergency: it's a gas. Emerg Med 1976; 305-314.
    67) Donnelly SC & FitzGerald MX: Reactive airways dysfunction syndrome (RADS) due to chlorine gas exposure. IJMS 1990; 159:275-277.
    68) Douidar SM: Nebulized sodium bicarbonate in acute chlorine inhalation. Pediatric Emerg Care 1997; 13:406-407.
    69) DuPont: DuPont Suit Smart: Interactive Tool for the Selection of Protective Apparel. DuPont. Wilmington, DE. 2002. Available from URL: http://personalprotection.dupont.com/protectiveapparel/suitsmart/smartsuit2/na_english.asp. As accessed 10/31/2002.
    70) DuPont: Permeation Guide for DuPont Tychem Protective Fabrics. DuPont. Wilmington, DE. 2003. Available from URL: http://personalprotection.dupont.com/en/pdf/tyvektychem/pgcomplete20030128.pdf. As accessed 4/26/2004.
    71) DuPont: Permeation Test Results. DuPont. Wilmington, DE. 2002a. Available from URL: http://www.tyvekprotectiveapprl.com/databases/default.htm. As accessed 7/31/2002.
    72) EPA: Search results for Toxic Substances Control Act (TSCA) Inventory Chemicals. US Environmental Protection Agency, Substance Registry System, U.S. EPA's Office of Pollution Prevention and Toxics. Washington, DC. 2005. Available from URL: http://www.epa.gov/srs/.
    73) ERG: Emergency Response Guidebook. A Guidebook for First Responders During the Initial Phase of a Dangerous Goods/Hazardous Materials Incident, U.S. Department of Transportation, Research and Special Programs Administration, Washington, DC, 2004.
    74) Edwards IR, Temple WA, & Dobbinson TL: Acute chlorine poisoning from a high school experiment. NZ Med J 1983; 720-721.
    75) Ellenhorn MJ & Barceloux DG: Chlorine, in: Medical Toxicology, Elsevier, New York, NY, 1988, pp 878.
    76) Endrizzi J, Nobay F, Wiegand T, et al: Bronchoscopic findings associated with inhaled chlorine toxicity. J Emerg Med 2015; 49(4):e123-e125.
    77) Flete J, Calvo C, & Zuniga J: Intoxication of 76 children by chlorine gas. Human Toxicol 1986; 5:99-100.
    78) Gautrin D, Leroyer C, & Infante-Rivard C: Longitudinal assessment of airway caliber and responsiveness in workers exposed to chlorine. Am J Respir Crit Care Med 1999; 160:1232-1237.
    79) Gautrin D, Leroyer C, & Larcheveque J: Cross-sectional assessment of workers with repeated exposure to chlorine over a three year period. Eur Resp J 1995; 8:2046-2054.
    80) Gilchrist HL & Matz PB: Med Bull Vet Adm 1933; 9:229-270.
    81) Givan DC, Eigen H, & Tepper RS: Longitudinal evaluation of pulmonary function in an infant following chlorine gas exposure. Pediatr Pulmonol 1989; 6:191-194.
    82) Grant WM & Schuman JS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
    83) Grieve AW, Davis P, Dhillon S, et al: A clinical review of the management of frostbite. J R Army Med Corps 2011; 157(1):73-78.
    84) Guardian Manufacturing Group: Guardian Gloves Test Results. Guardian Manufacturing Group. Willard, OH. 2001. Available from URL: http://www.guardian-mfg.com/guardianmfg.html. As accessed 12/11/2001.
    85) Guloglu C, Kara IH, & Erten PG: Acute accidental exposure to chlorine gas in the Southeast of Turkey: a study of 106 cases. Environ Res 2002; 88:89-93.
    86) HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    87) HSDB: Hazardous Substances Data Bank. National Library of Medicine, Bethesday, MD (Internet Version), Micromedex, Inc, Greenwood Village, CO, 2002.
    88) HSDB: Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    89) Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486.
    90) Hallam MJ, Cubison T, Dheansa B, et al: Managing frostbite. BMJ 2010; 341:c5864-.
    91) Harbison RD: Hamilton & Hardy's Industrial Toxicology, 5th ed, Mosby-Year Books, St. Louis, MO, 1998.
    92) Hasan FM, Gehshan A, & Fuleihan FJD: Resolution of pulmonary dysfunction following acute chlorine exposure. Arch Environ Health 1983; 38:76-80.
    93) Hathaway GJ, Proctor NH, & Hughes JP: Chemical Hazards of the Workplace, 4th ed, Van Nostrand Reinhold Company, New York, NY, 1996.
    94) Hazen SL, Hsu FF, & Mueller DM: Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 1996; 98:1283-1289.
    95) Hedges JR & Morrissey WL: Acute chlorine gas exposure. JACEP 1979; 8:59-63.
    96) Heidemann SM & Goetting MG: Treatment of acute hypoxemic respiratory failure caused by chlorine exposure. Pediatr Emerg Care 1991; 7:87-88.
    97) Henneberger PK, Lax MB, & Ferris BG Jr: Decrements in spirometry values associated with chlorine gassing events and pulp mill work. Am J Respir Crit Care Med 1996; 153:225-231.
    98) Hickmann MA, Nelson ED, & Siegel EG: Are high-dose toxic exposures always associated with reactive airways dysfunction syndrome (RADS)?. Arch Environ Health 2001; 56(5):439-442.
    99) Hryhorczuk D: Ammonia and chlorine. Clin Toxicol Rev 1986; 9:1-3.
    100) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide), 97, International Agency for Research on Cancer, Lyon, France, 2008.
    101) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol, 88, International Agency for Research on Cancer, Lyon, France, 2006.
    102) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Household Use of Solid Fuels and High-temperature Frying, 95, International Agency for Research on Cancer, Lyon, France, 2010a.
    103) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, 89, International Agency for Research on Cancer, Lyon, France, 2007.
    104) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, 92, International Agency for Research on Cancer, Lyon, France, 2010.
    105) IARC: List of all agents, mixtures and exposures evaluated to date - IARC Monographs: Overall Evaluations of Carcinogenicity to Humans, Volumes 1-88, 1972-PRESENT. World Health Organization, International Agency for Research on Cancer. Lyon, FranceAvailable from URL: http://monographs.iarc.fr/monoeval/crthall.html. As accessed Oct 07, 2004.
    106) ICAO: Technical Instructions for the Safe Transport of Dangerous Goods by Air, 2003-2004. International Civil Aviation Organization, Montreal, Quebec, Canada, 2002.
    107) ILC Dover, Inc.: Chemical Compatibility Chart. ILC Dover, Inc.. Frederica, DE. 1998a. Available from URL: http://www.ilcdover.com/WebDocs/chart.pdf; http://www.ilcdover.com/Products/ProtSuits/Ready1/chart.htm. As accessed 12/15/2001.
    108) ILC Dover, Inc.: Ready 1 The Chemturion Limited Use Chemical Protective Suit, ILC Dover, Inc., Frederica, DE, 1998.
    109) ILO: Encyclopaedia of Occupational Health and Safety, 3rd ed, Vols 1 & 2, International Labour Organization, Geneva, Switzerland, 1983.
    110) ITI: Toxic and Hazardous Industrial Chemicals Safety Manual, The International Technical Information Institute, Tokyo, Japan, 1995.
    111) International Agency for Research on Cancer (IARC): IARC monographs on the evaluation of carcinogenic risks to humans: list of classifications, volumes 1-116. International Agency for Research on Cancer (IARC). Lyon, France. 2016. Available from URL: http://monographs.iarc.fr/ENG/Classification/latest_classif.php. As accessed 2016-08-24.
    112) International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. Geneva, Switzerland. 2015. Available from URL: http://monographs.iarc.fr/ENG/Classification/. As accessed 2015-08-06.
    113) Jones RN, Hughes JM, & Glindmeyer H: Lung function after acute chlorine exposure. Am Rev Respir Dis 1986; 134:1190-1195.
    114) Kallen BA & Robert E: Drinking water chlorination and delivery outcome - a registry-based study in Sweden. Reprod Toxicol 2000; 14:303-309.
    115) Kanarek MS & Young TB: Drinking water treatment and risk of cancer death in Wisconsin. Environ Health Perspect 1982; 46:179-186.
    116) Kanitz S, Franco Y, & Patrone V: Association between drinking water disinfection and somatic parameters at birth. Environ Health Persp 1996; 104:516-520.
    117) Kanne JP, Thoongsuwan N, Parimon T, et al: Trauma cases from Harborview Medical Center. Airway injury after acute chlorine exposure. AJR Am J Roentgenol 2006; 186(1):232-233.
    118) Kappler, Inc.: Suit Smart. Kappler, Inc.. Guntersville, AL. 2001. Available from URL: http://www.kappler.com/suitsmart/smartsuit2/na_english.asp?select=1. As accessed 7/10/2001.
    119) Kennedy SM, Enarson DA, & Janssen RG: Lung health consequences of reported accidental chlorine gas exposures among pulpmill workers. Am Rev Respir Dis 1991; 143:74-79.
    120) Kilburn KH: Effects of chlorine and its cresylate byproducts on brain and lung performance. Arch Environ Health 2003; 58:746-754.
    121) Kim H, Haltmeier P, & Klotz JB: Evaluation of biomarkers of environmental exposures: urinary haloacetic acids associated with ingestion of chlorinated drinking water. Environ Res 1999; 80:187-195.
    122) Kimberly-Clark, Inc.: Chemical Test Results. Kimberly-Clark, Inc.. Atlanta, GA. 2002. Available from URL: http://www.kc-safety.com/tech_cres.html. As accessed 10/4/2002.
    123) Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
    124) Kose A, Kose B, Acikalin A, et al: Myocardial infarction, acute ischemic stroke, and hyperglycemia triggered by acute chlorine gas inhalation. Am J Emerg Med 2009; 27(8):1022-1024.
    125) LaCrosse-Rainfair: Safety Products, LaCrosse-Rainfair, Racine, WI, 1997.
    126) Lampe RM, Henderson AL, & Hansen GH: Green hair. JAMA 1977; 237:2092.
    127) Lawson JJ: Chlorine exposure: a challenge to the physician. Am Fam Phys 1981; 23:135-138.
    128) Lewis RJ: Hawley's Condensed Chemical Dictionary, 13th ed, John Wiley & Sons, Inc, New York, NY, 1997a.
    129) Lewis RJ: Hawley's Condensed Chemical Dictionary, 13th ed, Van Nostrand Reinhold Company, New York, NY, 1997, pp 249.
    130) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 10th ed, Van Nostrand Reinhold Company, New York, NY, 2000.
    131) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 9th ed, Van Nostrand Reinhold Company, New York, NY, 1996.
    132) Li B, Jia L, Shao D, et al: Pneumomediastinum from acute inhalation of chlorine gas in 2 young patients. Am J Emerg Med 2011; 29(3):357. e1-4.
    133) LoVecchio F, Blackwell S Stevens, Stevens D, et al: Outcomes of chlorine exposure: A five-year poison center experience (abstract). J Toxicol - Clin Toxicol 2002; 40(5):611.
    134) LoVecchio F, Blackwell S, & Stevens D: Outcomes of chlorine exposure: a 5-year poison center experience in 598 patients. Eur J Emerg Med 2005; 12:109-110.
    135) MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2003. Available from URL: http://www.mapaglove.com/pro/ChemicalSearch.asp. As accessed 4/21/2003.
    136) MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2004. Available from URL: http://www.mapaglove.com/ProductSearch.cfm?id=1. As accessed 6/10/2004.
    137) Maddy KT & Edmiston S: Selected incidents of illnesses and injuries related to exposure to pesticides reported by physicians in California in 1986. Vet Human Toxicol 1988; 30:246-254.
    138) Malo J-L, Cartier A, & Boulet L-P: Bronchial hyperresponsiveness can improve while spirometry plateaus two to three years after repeated exposure to chlorine causing respiratory symptoms. Am J Respir Crit Care Med 1994; 150:1142-1145.
    139) Mar-Mac Manufacturing, Inc: Product Literature, Protective Apparel, Mar-Mac Manufacturing, Inc., McBee, SC, 1995.
    140) Marigold Industrial: US Chemical Resistance Chart, on-line version. Marigold Industrial. Norcross, GA. 2003. Available from URL: www.marigoldindustrial.com/charts/uschart/uschart.html. As accessed 4/14/2003.
    141) Martinez TT & Long C: Explosion risk from swimming pool chlorinators and review of chlorine toxicity. Clin Toxicol 1995; 33:349-354.
    142) Meier JR: Environ Mutagen 1985; 7:201-211.
    143) Memphis Glove Company: Permeation Guide. Memphis Glove Company. Memphis, TN. 2001. Available from URL: http://www.memphisglove.com/permeation.html. As accessed 7/2/2001.
    144) Mohan A, Kumar SN, Rao MH, et al: Acute accidental exposure to chlorine gas: clinical presentation, pulmonary functions and outcomes. Indian J Chest Dis Allied Sci 2010; 52(3):149-152.
    145) Montgomery Safety Products: Montgomery Safety Products Chemical Resistant Glove Guide, Montgomery Safety Products, Canton, OH, 1995.
    146) Moore BB & Sherman M: Chronic reactive airway disease following acute chlorine gas exposure in an asymptomatic atopic patient. Chest 1991; 100:855-856.
    147) Morris RD, Audet AM, & Angelillo IF: Chlorination, chlorination by-products, and cancer: a meta-analysis. Am J Public Health 1992; 82:955-963.
    148) Mrvos R, Dean BS, & Krenzelok EP: Home exposures to chlorine/chloramine gas: review of 216 cases. South Med J 1993; 86:654-657.
    149) Murphy JV, Banwell PE, & Roberts AHN: Frostbite: pathogenesis and treatment. J Trauma 2000; 48:171-178.
    150) NFPA: Fire Protection Guide to Hazardous Materials, 11th ed, National Fire Protection Association, Quincy, MA, 1994.
    151) NFPA: Fire Protection Guide to Hazardous Materials, 12th ed, National Fire Protection Association, Quincy, MA, 1997.
    152) NFPA: Fire Protection Guide to Hazardous Materials, 13th ed., National Fire Protection Association, Quincy, MA, 2002.
    153) NFPA: Fire Protection Guide to Hazardous Materials, National Fire Protection Association, Quincy, MA, 1997a.
    154) NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07.
    155) NIOSH : Pocket Guide to Chemical Hazards (Internet Version). National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 1/2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    156) NIOSH: Pocket Guide to Chemical Hazards. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    157) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 1, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2001.
    158) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 2, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2002.
    159) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 3, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2003.
    160) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 4, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2004.
    161) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    162) Nat-Wear: Protective Clothing, Hazards Chart. Nat-Wear. Miora, NY. 2001. Available from URL: http://www.natwear.com/hazchart1.htm. As accessed 7/12/2001.
    163) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,3-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    164) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,4-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    165) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Butylene Oxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648083cdbb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    166) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Dibromoethane (Proposed). United States Environmental Protection Agency. Washington, DC. 2007g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802796db&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    167) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,3,5-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    168) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 2-Ethylhexyl Chloroformate (Proposed). United States Environmental Protection Agency. Washington, DC. 2007b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037904e&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    169) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Acrylonitrile (Proposed). United States Environmental Protection Agency. Washington, DC. 2007c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648028e6a3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    170) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Adamsite (Proposed). United States Environmental Protection Agency. Washington, DC. 2007h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    171) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Agent BZ (3-quinuclidinyl benzilate) (Proposed). United States Environmental Protection Agency. Washington, DC. 2007f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ad507&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    172) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Allyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039d9ee&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    173) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    174) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Arsenic Trioxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480220305&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    175) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Automotive Gasoline Unleaded (Proposed). United States Environmental Protection Agency. Washington, DC. 2009a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cc17&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    176) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Biphenyl (Proposed). United States Environmental Protection Agency. Washington, DC. 2005j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1b7&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    177) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bis-Chloromethyl Ether (BCME) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648022db11&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    178) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Boron Tribromide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae1d3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    179) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromine Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2007d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039732a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    180) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromoacetone (Proposed). United States Environmental Protection Agency. Washington, DC. 2008e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187bf&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    181) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Calcium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    182) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae328&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    183) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Sulfide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037ff26&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    184) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Chlorobenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803a52bb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    185) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Cyanogen (Proposed). United States Environmental Protection Agency. Washington, DC. 2008f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187fe&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    186) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Dimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbf3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    187) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Diphenylchloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    188) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091884e&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    189) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Phosphorodichloridate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480920347&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    190) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809203e7&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    191) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    192) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Germane (Proposed). United States Environmental Protection Agency. Washington, DC. 2008j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963906&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    193) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Hexafluoropropylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1f5&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    194) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ketene (Proposed). United States Environmental Protection Agency. Washington, DC. 2007. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ee7c&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    195) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    196) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    197) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Malathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2009k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809639df&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    198) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Mercury Vapor (Proposed). United States Environmental Protection Agency. Washington, DC. 2009b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a087&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    199) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Isothiocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a03&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    200) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a57&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    201) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl tertiary-butyl ether (Proposed). United States Environmental Protection Agency. Washington, DC. 2007a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802a4985&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    202) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methylchlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5f4&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    203) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    204) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c646&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    205) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN1 CAS Reg. No. 538-07-8) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    206) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN2 CAS Reg. No. 51-75-2) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    207) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN3 CAS Reg. No. 555-77-1) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    208) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Tetroxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091855b&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    209) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Trifluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e0c&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    210) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008o. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e32&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    211) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perchloryl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e268&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    212) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perfluoroisobutylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2009d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26a&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    213) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008p. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dd58&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    214) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2006d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020cc0c&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    215) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    216) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phorate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008q. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dcc8&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    217) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene (Draft-Revised). United States Environmental Protection Agency. Washington, DC. 2009e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a08a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    218) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene Oxime (Proposed). United States Environmental Protection Agency. Washington, DC. 2009f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26d&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    219) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    220) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    221) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Propargyl Alcohol (Proposed). United States Environmental Protection Agency. Washington, DC. 2006e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec91&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    222) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Selenium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec55&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    223) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Silane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d523&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    224) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    225) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    226) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Strontium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    227) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sulfuryl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec7a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    228) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tear Gas (Proposed). United States Environmental Protection Agency. Washington, DC. 2008s. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e551&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    229) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tellurium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e2a1&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    230) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tert-Octyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2008r. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5c7&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    231) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tetramethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-17.
    232) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    233) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7d608&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    234) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethylacetyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008t. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5cc&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    235) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Zinc Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    236) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for n-Butyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064808f9591&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    237) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    238) National Institute for Occupational Safety and Health: NIOSH Pocket Guide to Chemical Hazards, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Cincinnati, OH, 2007.
    239) National Research Council : Acute exposure guideline levels for selected airborne chemicals, 5, National Academies Press, Washington, DC, 2007.
    240) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 6, National Academies Press, Washington, DC, 2008.
    241) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 7, National Academies Press, Washington, DC, 2009.
    242) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 8, National Academies Press, Washington, DC, 2010.
    243) Neese Industries, Inc.: Fabric Properties Rating Chart. Neese Industries, Inc.. Gonzales, LA. 2003. Available from URL: http://www.neeseind.com/new/TechGroup.asp?Group=Fabric+Properties&Family=Technical. As accessed 4/15/2003.
    244) Noe JT: Therapy for chlorine gas inhalation. Ind Med Surg 1963; 32:411-414.
    245) North: Chemical Resistance Comparison Chart - Protective Footwear . North Safety. Cranston, RI. 2002. Available from URL: http://www.linkpath.com/index2gisufrm.php?t=N-USA1. As accessed April 30, 2004.
    246) North: eZ Guide Interactive Software. North Safety. Cranston, RI. 2002a. Available from URL: http://www.northsafety.com/feature1.htm. As accessed 8/31/2002.
    247) OHM/TADS : Oil and Hazardous Materials/Technical Assistance Data System. US Environmental Protection Agency. Washington, DC (Internet Version). Edition expires 2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    248) OSHA: Occupational Health Guideline for Chlorine, United States Department of Labor, Occupational Health and Safety Administration, Washington, DC, 1978.
    249) Parimon T, Kanne JP, & Pierson DJ: Acute inhalation injury with evidence of diffuse bronchiolitis following chlorine gas exposure at a swimming pool. Resp Care 2004; 49(3):291-294.
    250) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    251) Pherwani AV, Khanna SA, & Patel RB: Effect of chlorine gas leak on the pulmonary function of school children. Indian J Pediatr 1989; 56:125-128.
    252) Playtex: Fits Tough Jobs Like a Glove, Playtex, Westport, CT, 1995.
    253) Ploysongsang Y, Beach BC, & Dilisio RE: Pulmonary function changes after acute inhalation of chlorine gas. So Med J 1982; 75:23-26.
    254) Pohanish RP & Greene SA: Rapid Guide to Chemical Incompatibilities, Van Nostrand Reinhold Company, New York, NY, 1997.
    255) RTECS : Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2000; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    256) RTECS : Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 4/30/2001; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    257) Raffle PAB, Adams PH, & Baxter PJ: Hunter's Diseases of Occupations, Little, Brown & Co, Boston, MA, 1994.
    258) River City: Protective Wear Product Literature, River City, Memphis, TN, 1995.
    259) Safety 4: North Safety Products: Chemical Protection Guide. North Safety. Cranston, RI. 2002. Available from URL: http://www.safety4.com/guide/set_guide.htm. As accessed 8/14/2002.
    260) Salisbury DA, Enarson DA, & Chan-Yeung M: First-aid reports of acute chlorine gassing among pulpmill workers as predictors of lung health consequences. Am J Ind Med 1991; 20:71-81.
    261) Schins RP, Emmen H, & Hoogendijk L: Nasal inflammatory and respiratory parameters in human volunteers during and after repeated exposure to chlorine. Eur Respir J 2000; 16:626-632.
    262) Schonhofer B, Voshaar T, & Kohler D: Long-term lung sequelae following accidental chlorine gas exposure. Respiration 1996; 63:155-159.
    263) Schwartz DA, Smith DD, & Lakshminarayan S: The pulmonary sequelae associated with accidental inhalation of chlorine gas. Chest 1990; 97:820-825.
    264) Servus: Norcross Safety Products, Servus Rubber, Servus, Rock Island, IL, 1995.
    265) Sexton JD & Pronchik DJ: Chlorine Inhalation: The Big Picture. Clin Toxicol 1998; 36:87-93.
    266) Shroff CP, Khade MV, & Srinivasan M: Respiratory cytopathology in chlorine gas toxicity: A study in 28 subjects. Diagnostic Cytopathol 1988; 4:28-32.
    267) Shusterman DJ, Murphy MA, & Balmes JR: Subjects with seasonal allergic rhinitis and nonrhinitic subjects react differently to nasal provocation with chlorine gas. J Allergy Clin Immunol 1998; 101:732-740.
    268) Siemiatycki J, Dewar R, & Nadon L: Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol 1994; 140:1061-1080.
    269) Sittig M: Handbook of Toxic and Hazardous Chemicals and Carcinogens, 3rd ed, Noyes Publications, Park Ridge, NJ, 1991.
    270) Standard Safety Equipment: Product Literature, Standard Safety Equipment, McHenry, IL, 1995.
    271) Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011.
    272) Szerlip HM & Singer I: Hyperchloremic metabolic acidosis after chlorine inhalation. Am J Med 1984; 77:581-582.
    273) Taylor AJN & Venables KM: Clinical and epidemiological methods in investigating occupational asthma. Clin Immunol Allergy 1984; 4:3-17.
    274) Tingley: Chemical Degradation for Footwear and Clothing. Tingley. South Plainfield, NJ. 2002. Available from URL: http://www.tingleyrubber.com/tingley/Guide_ChemDeg.pdf. As accessed 10/16/2002.
    275) Traub SJ, Hoffman RS, & Nelson LS: Case report and literature review of chlorine gas toxicity. Vet Human Toxicol 2002; 44(4):235-239.
    276) Trelleborg-Viking, Inc.: Chemical and Biological Tests (database). Trelleborg-Viking, Inc.. Portsmouth, NH. 2002. Available from URL: http://www.trelleborg.com/protective/. As accessed 10/18/2002.
    277) Trelleborg-Viking, Inc.: Trellchem Chemical Protective Suits, Interactive manual & Chemical Database. Trelleborg-Viking, Inc.. Portsmouth, NH. 2001.
    278) U.S. Department of Energy, Office of Emergency Management: Protective Action Criteria (PAC) with AEGLs, ERPGs, & TEELs: Rev. 26 for chemicals of concern. U.S. Department of Energy, Office of Emergency Management. Washington, DC. 2010. Available from URL: http://www.hss.doe.gov/HealthSafety/WSHP/Chem_Safety/teel.html. As accessed 2011-06-27.
    279) U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project : 11th Report on Carcinogens. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Washington, DC. 2005. Available from URL: http://ntp.niehs.nih.gov/INDEXA5E1.HTM?objectid=32BA9724-F1F6-975E-7FCE50709CB4C932. As accessed 2011-06-27.
    280) U.S. Environmental Protection Agency: Discarded commercial chemical products, off-specification species, container residues, and spill residues thereof. Environmental Protection Agency's (EPA) Resource Conservation and Recovery Act (RCRA); List of hazardous substances and reportable quantities 2010b; 40CFR(261.33, e-f):77-.
    281) U.S. Environmental Protection Agency: Integrated Risk Information System (IRIS). U.S. Environmental Protection Agency. Washington, DC. 2011. Available from URL: http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList&list_type=date. As accessed 2011-06-21.
    282) U.S. Environmental Protection Agency: List of Radionuclides. U.S. Environmental Protection Agency. Washington, DC. 2010a. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    283) U.S. Environmental Protection Agency: List of hazardous substances and reportable quantities. U.S. Environmental Protection Agency. Washington, DC. 2010. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    284) U.S. Environmental Protection Agency: The list of extremely hazardous substances and their threshold planning quantities (CAS Number Order). U.S. Environmental Protection Agency. Washington, DC. 2010c. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-part355.pdf. As accessed 2011-06-17.
    285) U.S. Occupational Safety and Health Administration: Part 1910 - Occupational safety and health standards (continued) Occupational Safety, and Health Administration's (OSHA) list of highly hazardous chemicals, toxics and reactives. Subpart Z - toxic and hazardous substances. CFR 2010 2010; Vol6(SEC1910):7-.
    286) U.S. Occupational Safety, and Health Administration (OSHA): Process safety management of highly hazardous chemicals. 29 CFR 2010 2010; 29(1910.119):348-.
    287) United States Environmental Protection Agency Office of Pollution Prevention and Toxics: Acute Exposure Guideline Levels (AEGLs) for Vinyl Acetate (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6af&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    288) Urben PG: Bretherick's Handbook of Reactive Chemical Hazards & CD-ROM, 6th ed, Butterworth-Heinemann Ltd, Oxford, England, 1999.
    289) Van Sickle D, Wenck MA, Belflower A, et al: Acute health effects after exposure to chlorine gas released after a train derailment. Am J Emerg Med 2009; 27(1):1-7.
    290) Vinsel PS: Treatment of acute chlorine gas inhalation with nebulized sodium bicarbonate. J Emerg Med 1990; 8:327-329.
    291) Vohra R & Clark RF: Chlorine-related inhalation injury from a swimming pool disinfectant in a 9-year-old girl. Pediatr Emerg Care 2006; 22(4):254-257.
    292) Wang J, Zhang L, & Walther SM: Administration of aerosolized terbutaline and budesonide reduces chlorine gas-induced acute lung injury. J Trauma 2004; 56:850-862.
    293) Weast RC: Handbook of Chemistry and Physics, 69th Ed, CRC Press, Inc, Boca Raton, FL, 1989.
    294) Weill H, George R, & Schwarz M: Late evaluation of pulmonary function after acute exposure to chlorine gas. Am Review of Resp Disease 1969; 99:374-378.
    295) Weisel CP, Kim H, & Haltmeier P: Exposure estimates to disinfection by-products of chlorinated drinking water. Environ Health Perspect 1999; 107:103-110.
    296) Wells Lamont Industrial: Chemical Resistant Glove Application Chart. Wells Lamont Industrial. Morton Grove, IL. 2002. Available from URL: http://www.wellslamontindustry.com. As accessed 10/31/2002.
    297) Williams JG: Inhalation of chlorine gas. Postgrad Med J 1997; 73:697-700.
    298) Willson DF, Truwit JD, Conaway MR, et al: The Adult Calfactant in Acute Respiratory Distress Syndrome (CARDS) Trial. Chest 2015; Epub:Epub.
    299) Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.
    300) Winder C: The toxicology of chlorine. Environ Res 2001; 85:105-114.
    301) Wolf DC, Morgan KT, & Gross EA: Two-year inhalation exposure of female and male B6C3F1 mice and F344 rats to chlorine gas induces lesions confined to the nose. Fundam Appl Toxicol 1995; 24:111-131.
    302) Wood BR, Colombo JL, & Benson BE: Chlorine inhalation toxicity from vapors generated by swimming pool chlorinator tablets. Pediatrics 1987; 79:427-430.
    303) Workrite: Chemical Splash Protection Garments, Technical Data and Application Guide, W.L. Gore Material Chemical Resistance Guide, Workrite, Oxnard, CA, 1997.
    304) Zenz C: Occupational Medicine, 3rd ed, Mosby-Year Book, Inc, St Louis, MO, 1994.
    305) Zierler S, Feingold L, & Danley RA: Bladder cancer in Massachusetts related to chlorinated and chloraminated drinking water: a case-control study. Arch Environ Health 1988; 43:195-200.